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ABSTRACT 
 
Investigations of human biology and disease have been hindered by the use of animal 
models. The information obtained from such studies often results in clinically irrelevant results 
and drug trial failures. Additionally, several governing bodies have been formulating legislation 
to move away from animal models and toward more ethical and efficient testing platforms for 
drug discovery and cosmetic research. As an answer to these issues, “body-on-a-chip” systems 
have been a rapidly developing field which easily recapitulates in vivo functionality, providing a 
more relevant, repeatable, and ethical testing platform to better predict biology. These systems 
can be used as human-based testing platforms to evaluate human physiology, disease 
progression, and drug responsiveness for specific cell types and multi-organ systems. Diseases 
such as amyotrophic lateral sclerosis (ALS) and spinal muscular atrophy (SMA) have significant 
research challenges, specifically with translating research findings into treatment plans. The 
complexity of the neuromuscular reflex arc, the biological system affected by these diseases, is 
difficult to study with traditional molecular techniques, namely because the many components of 
this disease system interact with each other using complex pathways. This work pushes the 
existing platform to a more complete human model of neuromuscular disease with the 
incorporation of gamma motoneurons, development of the first human induced pluripotent cell 
(iPSC) derived intrafusal fibers, and proposals to incorporate nociceptive neurons all on a 
functionally interrogative platform. The incorporation of these components will allow for a more 
complete, clinically relevant model to study neuromuscular disorders and for preclinical dug 
discovery.   
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CHAPTER ONE: INTRODUCTION 
 
Investigations of human disease is an enormous motivator for the progression of scientific 
inquiry. The utilization of animal models has provided a way to investigate drugs and other 
products used by humans for efficacy and potential hazards. Unfortunately, animal modeling has 
several pitfalls which are influencing the outcome of research pertaining to clinical trials and 
disease modeling(1). Also, several governing bodies have chosen to move toward more ethical 
and high-throughput methods of human-based biological inquiry. As an answer to these concerns 
more in vitro testing platforms have become a large area of interest in the scientific community. 
More specifically, “body-on-a-chip” technology can integrate modern micro-scale engineering 
along with human-based investigational platforms to provide an ethical way of predicting clinical 
trials and testing the effects of drugs and cosmetics (1). This technology has already been used to 
model several single and multi-organ systems (1-10), providing a platform of in vitro 
investigation for human pathology and drug discovery. Further development of these systems 
will allow for a more comprehensive array of high-throughput platforms for human biology 
investigation 
While several platforms have been developed for interrogating human organ systems, the 
neuromuscular reflex arc is a complex system that needs further development to be more 
representative of in vitro biology. This system is very complex and has multiple interacting cell 
types, each of which can mediate disease states and drug efficacy (11, 12). The neuromuscular 
reflex arc has two basic cell types (neurons and muscle) each of which has their own further 
subcategories of cell types. Motoneurons are an efferent neurons that sends signals from the 
central nervous system (CNS) to the periphery (13). Motoneurons typically innervate extrafusal 
fibers, the contractile component of muscle tissue. Upon stimulation from the motoneurons, 
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these fibers can contract and relax, controlling limb position, dexterity, and strength. Conversely, 
there is an afferent component to this system. Embedded within the extrafusal fibers are muscle 
spindles. These are encapsulations of specialized muscle fibers called intrafusal fibers. These act 
as the sensory organ of muscle tissue (14). They are innervated by sensory neurons and relay 
information regarding muscle tension, speed of contraction or relaxation, and proprioception up 
through afferent sensory neurons and up to the CNS (15). Additionally, there are specialized 
motoneurons (γ-motoneurons) which innervate these intrafusal fibers of the muscle spindle (16). 
They send the intrafusal fibers signals to contract or relax in response to muscle length in order 
to maintain an efficient feedback loop. There has also been evidence of nociceptive nerve 
endings within the muscle spindle (17). These neurons are responsible for conveying sensations 
of pain up to the CNS. Collectively, these cell types interact with may intrinsic feedback systems 
which do not accurately depict human physiology or disease states. Therefore, it is integral to the 
progression of neuromuscular research to find an alternative model for investigating 
neuromuscular diseases and potential drug treatments with more clinically relevant, human-
based results.  
To further the clinical relevance of this technology, investigating the integration of  induced 
pluripotent stem cells (iPSCs) have become a relevant inquiry (11). These cells are obtained 
from  simple procedures, namely biopsies, and are treated to reverse the differentiation process. 
These cells can then be differentiated into a wide variety of cell types, allowing for the 
investigation of disease with complex genetic and posttranslational onsets as well as a more 
personalized approach for specific diseases or biological variants within a range. Integration of 
this technology with “body-on-a-chip” platforms advance the potential for having personalized 
medicine and a testing platform that can relate functional in vitro data to clinical outcomes. 
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CHAPTER TWO: TISSUE ENGINEERING THE MECHANOSENSORY 
CURCUIT OF THE STRETCH REFLEX ARC WITH HUMAN STEM 
CELLS: SENSORY NEURON INNERVATION OF INTRAFUSAL FIBERS 
 
The work in this chapter was published as listed below and, as per the publication agreement,  
does not require permission for use in this thesis. 
Guo, X., Colon, A., Akanda, N., Spradling, S., Stancescu, M., Martin, C., & Hickman, J. J. 
(2017). Tissue engineering the mechanosensory circuit of the stretch reflex arc with human stem 
cells: Sensory neuron innervation of intrafusal muscle fibers. Biomaterials, 122, 179–187. 
doi:10.1016/j.biomaterials.2017.01.005 
Introduction 
 
Proprioception is the sensation of axial body position and the awareness of limb and body 
movement through space. Muscle spindle fibers, or muscle mechanoreceptors, are small 
encapsulated sensory organs that lie in parallel with skeletal (extrafusal or contractile) muscle 
fibers. While extrafusal muscle fibers generate force via muscle contraction to initiate skeletal 
movement, intrafusal fibers serve as musculoskeletal sensory organs to detect the amount and 
rate of change of muscle length and monitor muscle position (proprioceptors). This mechanical 
information is converted to electrical action potentials which are then sent to the central nervous 
system (CNS) through its connection with proprioceptive type Ia and type II sensory neurons 
(18, 19). Reciprocally, after integrating the inputs from sensory neurons and those from the 
motor cortex through corticospinal tract, the CNS can regulate motor activity through 
motoneurons (MNs): α MNs for extrafusal fibers to induce muscle contraction and γ MNs for 
intrafusal fibers to modulate the sensitivity of the proprioceptors. Despite their lower number in 
human muscle compared to extrafusal fibers(20), intrafusal fibers are indispensable for 
4 
 
proprioception and coordination of movement. Impairment of this sensory circuit can cause 
motor deficits, especially in fine or coordinated motor activity (21, 22). This proprioceptive 
system has been extensively investigated with animal models (23, 24), but research to address 
function in human systems has been gaining increased attention. A representative clinical 
problem is human deafferentation, in which a patient loses their afferent sensory input due to a 
number of causes, including neuropathy (25). In the absence of proprioceptive feedback, these 
patients suffer difficulties in motor control. They cannot control the magnitude and speed of the 
motion of their limbs leading to problems in balance and gait (26). Basic life skills such as 
mastication, swallowing, even walking can become difficult unless the patient exerts increased 
levels of mental concentration and visual monitoring (27, 28). In addition, impairment of 
proprioceptive sensory feedback has been found in a wide range of diseases such as autism, 
ADHD (29), Parkinson’s disease (30), Huntington’s disease, dystonia (31), neuropathy (27) and 
multiple sclerosis (32). However, deficits in proprioception and motor control may only be a side 
effect of the disease and therefore not a primary focus in the investigation of these diseases. 
However, these side effects do cause significant impact to their clinical symptoms and quality of 
a patient’s life(28, 30). Pathology of the proprioceptive function could be caused by deficits in 
central integration of sensory and motor systems such as in neurodegenerative/development 
diseases like Parkinson’s and autism (30, 33), or by direct damage to the intrafusal sensory 
system such as in deafferentation due to neuropathy which can be induced by immune system 
attack, viral infection, drug toxicity or other pathological conditions (25, 28, 32). Developing an 
in vitro model of this circuit would not only provide a valuable platform for the investigation of 
developmental, physiology as well as function of the somatosensory-motor system, but also for 
the construction of relevant disease models. Due to difficulties in translating the findings from 
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animal models to clinical applications, human-based in vitro systems are becoming increasingly 
utilized for etiological studies and for drug development. The rapid expansion of the availability 
of stem cells in recent years has provided an avenue for the unlimited supply of human cells for 
tissues, and a straightforward way to generate desired cell types. In addition, induced pluripotent 
stem cells (iPSC) technology provides the flexibility to investigate patient genetic diversity in 
these in vitro models. Our goal was to develop a human-based, in vitro muscle-sensory neuron 
circuit utilizing human stem cells as the source of the intrafusal fibers and sensory neurons, and 
to establish and characterize the resultant intrafusal innervations. Intrafusal muscle fibers have 
been induced in vitro from rat embryonic muscle cells (34), and the establishment of connections 
with rat sensory neurons from primary DRG neurons in a defined in vitro system has previously 
been demonstrated (14). In vitro induction of intrafusal fibers from human myoblasts had also 
been reported but by utilizing a serum-containing system and with a focus on molecular 
mechanism of signal transduction (35). We have successfully differentiated functional myotubes 
(extrafusal fibers) from human satellite cells (36), then co- cultured them in a serum-free defined 
medium with motoneurons (MNs) to form NMJs (37). We have also differentiated functional 
proprioceptive sensory neurons from human neural progenitors (38). The identity of these 
sensory neurons has been confirmed by the expression of sensory neuron markers Brn3a and 
peripherin, and their proprioceptive identity has been further confirmed by the markers of 
parvalbumin and vGluT1 (38). In this study, we generated intrafusal fibers from human satellite 
cells and established innervation by the stem cell-derived human proprioceptive sensory neurons 
and established functional connections. Surprisingly, the intrafusal fibers were capable of 
repetitively firing upon stimulation, which hadn’t previously been observed in any extrafusal 
myofibers (36, 39) or rat intrafusal myofibers (34). This human-based, in vitro mechanosensory 
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model could find important applications in the etiological study of relevant diseases such as 
deafferentiation, neuropathies and possibly neuropathic pain. It could also provide a plausible 
phenotypic model for the drug screening and potential therapy development for these diseases 
 
Results 
 
Development of a defined system for the induction of intrafusal fibers, utilizing a serum-free 
medium 
 
Considering the common origin, environment and multiple needs shared by both intrafusal and 
extrafusal fibers during development, the protocol for generating functional extrafusal fibers (14, 
34) developed in our laboratory was used as a starting point for designing protocols for intrafusal 
fiber induction. As previously reported, neuregulin 1-β-1 (NRG) is necessary for the 
specification of nuclear bag fibers and for spindle development (35, 40). Additionally, the basal 
laminar molecules, laminin and agrin, are especially important for NRG signaling for intrafusal 
induction by activating a dystroglycan receptor on the myotube membrane which then 
potentiates the NRG-Egr3 signaling pathway (41). Therefore, these three factors, NRG, laminin 
and agrin, were included in the differentiation process. The composition of medium 2 is as 
described in Table 2. 
Phase contrast evaluation of the induction of intrafusal fibers 
 
The human satellite cells were plated, expanded and differentiated as described in the Methods. 
Myocyte fusion was initiated after switching to medium 1, which defines the start of the 
differentiation process, and multinuclear myocytes were evident after 3~4 days in vitro. The 
cultures are then switched to medium 2 and multinuclear myotubes continued to mature as 
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indicated by more individualized myotubes with better defined morphology under phase 
microscopy. Starting approximately at day 7, myofibers with morphology consistent with bag 
fibers could be identified and were increasingly evident and numerous as the culture matured. 
Some demonstrated equatorial nucleation which is typical for bag fibers (18, 42) (Figure1 A, C). 
Myofibers with a chain of nuclei were also observed frequently and identified as chain fibers 
(Figure 1 B). During development, nuclear bag morphology is thought to be the earliest reliable 
feature for identifying young intrafusal fiber bundles in human muscle (42), however, the 
identification of chain fibers under phase microscopy in not as well defined. Thus, the number of 
induced muscle bag fibers was used to optimize the induction protocol. To determine whether 
the generation of bag fibers was NRG-dependent as postulated from in vivo studies(43), the 
percentage of bag fibers over the total number of myofibers was compared with control cultures 
in which the three factors were omitted (NRG, laminin and agrin). Also, to determine the optimal 
timing of factor addition, the percentage of bag fibers was analyzed from factors inclusive from 
day 0, 4 & 7 of differentiation in medium 1. As displayed in Figure 1 D, inclusion of the three 
factors caused a significant increase of the percentage of bag fibers from 3.02 +/- 3.95% to at 
least 15.80 +/- 6.62% (P<0.05) But there is no significant difference when added at different 
time points during differentiation in medium 1. Later analysis indicated that switching to 
medium 2 on day 4 generated more consistent results in intrafusal induction than on day 7. 
Therefore, cells were induced for 4 days in medium 1 before switching to medium 2 in all 
subsequent experiments. 
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Figure 1: Phase contrast micrographs. A) A bag fiber in an induced culture after 16 days of 
differentiation. Note the equatorial distribution of multiple nuclei in the bag-shaped myofiber. 
Scale bar: 20 μm. B) A chain fiber in an induced culture after 16 days of differentiation. Note the 
linear assembly of the nuclei inside the myotube. Scale bar: 20 μm. C) A low magnification 
image of an induced culture after 17 days of differentiation. Scale bar: 80 μm. D) Graph 
comparison of the percentage of bag fibers when NRG/LMN/FN was added to the culture at 
different times during differentiation (* means P<0.05). 
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Immunocytochemical evaluation of intrafusal fiber induction  
 
Immunostaining was used to confirm the identity of the induced bag fibers. The hSKM culture 
treated with NRG/LMN/Agrin as described above, was evaluated for the expression of the bag 
fiber-specific myosin heavy chain (MHC) with the S46 antibody (44, 45). As indicated in Figure 
2 A, a sub-population of myofibers expressed the slow tonic MHC and were identified as S46-
positive myotubes. In addition, these bag fibers expressed α cardiac-like MHC which was 
indicated by immunocytochemical staining with the BA-G5 antibody (Figure 2 C) (44, 46). In 
vivo, NRG induction functions through the ErbB2 receptor (47). Its activation through 
phosphorylation can then increase the expression of the transcription factor Egr3 (43), which 
triggers downstream genes that then delineate intrafusal fiber differentiation. Therefore, the 
induced cultures were analyzed for the expression and distribution of phosphorylated ErbB2 
(ErbB2-℗) and Egr3 (Figure 3). ErbB2-℗ was specific for a subset of myofibers and was found 
in all S46- positive myotubes (Figure 3 A). The induced cultures were then analyzed for the 
expression of Egr3, the intrafusal fiber-specific transcription factor. As in Figure 3 B&C, Egr3 
was found to be expressed in bag fibers which were also identified by staining for the S46-
antibody. Both the expression of ErbB2-℗ and Egr3 in the induced intrafusal fibers suggest the 
activation of the ErbB2 receptor-mediated signaling pathway by NRG treatment, similar to what 
occurs during in vivo development. 
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Figure 2: A&B) Immunocytochemistry of induced intrafusal muscle cultures stained with the 
bag fiber-specific antibody S46 (green), and co-stained with Phalloidin (red) which is a general 
marker for all myofibers. A) A representative bag fiber is highlighted with a yellow arrow and a 
blue arrow indicates a myofiber that was partially stained by S46 but did not present apparent 
bag morphology, suggests the possibility of chain fiber or an emerging bag fiber formation. B) 
An image of a bag-fiber at higher magnification. C) A bag fiber immunostained with the BA-G5 
antibody. 
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Figure 3: Activation of Neuregulin signaling pathway demonstrated by immunocytochemistry. 
A) Co-immunostaining of Phalloidin and erbB2-℗. To visualize the erbB2-℗ clusters on the cell 
membrane, two regions of the low magnification image were enlarged. Image a’ and b’ are the 
higher magnifications of regions a and b respectively. Abundant erbB2-℗ signals (indicated by 
arrows) were observed only on multi-nuclei bag fibers (b and b’), and rarely observed on the 
others (a and a’). B) Immunostaining of Egr3 co-stained with S46. Egr3-positivity was only 
observed in S46-positive myofibers, confirming its specificity. C) A bag fiber under higher 
magnification. 
Immunocytochemical evaluation of sensory nerve endings on intrafusal fibers  
 
The induced intrafusal fibers were co-cultured with human stem cell-derived sensory neurons 
(38) and evaluated for innervation characteristic of this mechanosensory system. The 
differentiated sensory neurons were added to the partially differentiated muscle culture (after 
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step 1 differentiation) and co-cultured for approximately 10 days (Figure 8). Both sensory 
neurons and intrafusal fibers survived well in the co-culture system as indicated by the phase 
images (Figure 4 A). In order to evaluate the synaptic connections the co-cultures were 
immunostained with the sensory neuron marker peripherin and the intrafusal marker BA-G5. In 
vivo sensory nerve endings on intrafusal fibers normally demonstrate two distinct morphological 
structures: annulospiral wrappings (ASWs) and flower spray endings (FSEs) (18). As shown in 
Figure 5 B-C, both terminal structures were observed in the developed co-culture system. An 
example of the annulospiral association between sensory terminals and the intrafusal fibers is 
demonstrated in the detailed optical series depicted in Figure 5. 
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Figure 4: Immunocytochemical analysis of the co-culture of human sensory neurons and 
intrafusal fibers indicates connectivity. A) Phase image of a Day 10 co-culture. Note the 
pseudounipolar sensory neuron (orange arrow) and bipolar sensory neuron (red arrow) in the 
vicinity of a bag-shaped myofiber. B&C) Co-immunostaining of Peripherin and BA-G5 revealed 
two typical sensory terminal structures around intrafusal fibers: annulospiral wrappings (B) and 
flower spray endings (C), as indicated by the arrows in both images 
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Figure 5: Optical section of a sensory terminal structure indicating annulospiral wrappings on 
intrafusal fibers immunostained with Peripherin and BA-G5. A) Projected image of an intrafusal 
fiber with sensory axons. B) Series of optical sections of the intrafusal fiber demonstrated in A). 
Electrophysiological properties of intrafusal fibers in the co-culture  
 
The electrophysiological properties of the intrafusal fibers in the co-culture were evaluated using 
voltage and current clamp recordings. Representative voltage-clamp and current-clamp 
recordings for intrafusal fibers are shown in Figure 6. Similar to extrafusal fibers (7, 36), 
intrafusal fibers demonstrated prominent sodium and potassium currents and generated action 
potentials. Most interestingly repetitive firing was observed in 10 out or 19 bag fibers recorded in 
the system (Figure 6 B). The electrophysiological properties of intrafusal fibers are listed in 
Table 1. 
15 
 
 
Figure 6: Patch clamp recording from intrafusal fibers in the co-culture system. A) Phase 
micrograph of the recorded cell. B) Current clamp recording indicating repetitive firing of APs. 
C) An example trace of active Na+ and K+ currents from a voltage clamp recording. D) An 
example trace of an Action Potential (AP) elicited when the cell received a saturated stimulus (2 
msec 200pA inward current). 
 
 
 
 
16 
 
Table 1: Electrophysiological properties of induced intrafusal bag fibers in the co-culture with 
human sensory neurons 
 Resting 
Membrane 
Potential 
(mV) 
Membrane 
Resistance 
(MΩ) 
Membrane 
Capacitance 
(pF) 
No. of 
Aps (s) 
Inward 
Current 
(pA) 
Outward 
Current 
(pA) 
AP 
Amplitude 
(mv) 
Average 
+/- STDEV 
-53.0 +/- 
9.6 
365.2 +/- 
235.9 
207.9 +/- 
65.0 
3.1 +/- 
2.5 
5043.6 
+/- 
1888.8 
1932.3 +/- 
1311.9 
95.9 +/- 
11.5 
 
Immunocytochemical analysis indicates innervation of intrafusal fibers by human sensory 
neurons  
 
To examine in detail the connections between the sensory neuron terminals and intrafusal fibers, 
the co-culture was analyzed by immunostaining with PICK1 (PRKCA-binding protein) and 
peripherin. PICK1 contains a PDZ domain and functions as an adaptor protein that organizes a 
variety of membrane proteins including the stretch sensitive sodium channel BNaC1 on the 
membrane of intrafusal fibers. Co-localization of PICK1 with nerve terminals was observed. 
Figure 7 demonstrates an example of a flower spray endings associated with a myofiber and its 
co-localization with PICK1, suggesting a functional connection between intrafusal fibers with 
the axonal terminals of sensory neurons, which is a key connection for mechanosensory function. 
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Figure 7: Immunocytochemical analysis of the connection of human sensory neurons and 
intrafusal fibers from a day 5 co-culture by co-immunostaining with PICK1 and Neurofilament 
antibodies. Co-localization of PICK1 expression on the myofiber at the neural terminal ending 
site is indicated by the arrow 
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Discussion 
 
This study reports the de novo induction of human intrafusal skeletal muscle fibers from satellite 
cells and their synaptic connection with human stem cell-derived sensory neurons in a defined in 
vitro system. The induction of intrafusal fibers was characterized by morphology and fiber-type 
specific transcription factor expression using phase microscopy and immunocytochemistry. The 
connections between sensory neurons and the intrafusal fibers were observed morphologically 
type-specific innervation patterns using phase microscopy and immunocytochemistry. The 
functional maturity of the induced intrafusal fibers was confirmed by patch-clamp 
electrophysiological analysis. During development, induction of muscle spindles depends on 
trophic factors released by sensory neurons. Neuregulin (NRG), specifically the Ig-Nrg1 isoform, 
is a proteoglycan released by type Ia proprioceptive sensory neurons and is sufficient to induce 
muscle spindle differentiation in vivo (43). The NRG-ErbB2-Egr3 signaling pathway has been 
proposed to be the central pathway for this effect (19). Mice with a conditional knockout of 
ErbB2 have progressive defects in proprioception due to the loss of muscle spindles (21). Egr3 
has an essential role for the phenotypic differentiation of spindles (48) and mice deficient in Egr3 
have gait ataxia and lack muscle spindles (49). Therefore, it is hypothesized that NRG released 
by sensory axons, through the activation of ErbB2 receptors on the myotube membrane, can turn 
on the transcription factors Egr3/Pea3/Erm, which then initiates downstream genes and 
delineates the differentiation of intrafusal fibers and muscle spindles (19, 21, 35, 40, 48, 49). In 
addition to this major pathway, the basal laminar molecules, laminin and agrin, are especially 
important for NRG signaling and intrafusal induction by activating a dystroglycan receptor on 
the myotube membrane which then potentiates the NRG-Egr3 signaling pathway (41). In this 
study, both pathways were employed for the in vitro induction of intrafusal myofibers as 
19 
 
evidenced by the increased expression of ErbB2-℗ and Egr3 in BA-G5-positive myotubes. The 
electrical function of the induced intrafusal fibers was confirmed by patch-clamp 
electrophysiological analysis. However, these results differed from previous experiments with 
human extrafusal fibers, which only fire a single action potential during depolarization (36), in 
that the majority (53%) of the intrafusal fibers examined exhibited repetitive firing. The rest fired 
single action potentials probably due to maturation issues. This repetitive firing phenomenon has 
not been observed in the electrophysiology of rat intrafusal fibers (34). This is the first 
electrophysiological analysis of human intrafusal fibers and the first report concerning the unique 
electrophysiological property of these myotubes. This unique electrophysiological result for a 
human muscle fiber may actually be intrinsic to its function as a mechano-electrical transducer. 
Sensory receptors of multiple modalities utilize firing frequency to encode stimulus intensity 
such as the sensing of temperature, pain and touch (50-54). Thus, repetitive firing may be 
important for the normal function of these sensory transducers, endowing them the potential to 
code stimulus intensity with firing frequency. This result is in agreement with numerous previous 
studies from human microneurography, an in vivo approach to monitor the impulses in sensory 
nerves while applying the stimulus, such as touch or movement (54, 55). All the dynamic 
responses of human muscle intrafusal sensory afferents from these studies displayed multiple 
discharges at various frequencies depending on the stimulation protocols (54, 56-58). Overall, 
these results establish that there are important electrophysiological differences between intrafusal 
and extrafusal fibers, and also between human intrafusal and rat intrafusal fibers, which could 
have new implications for understanding muscle physiology. In vitro systems composed of the 
main component of the specialized stretch receptors could allow studies of perception and 
coordination of limb movement in a defined, controlled system. Mice lacking spindle fibers 
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within skeletal muscle present with profound gait ataxia and other motor deficits (49). 
Impairment of proprioception has been well represented in deafferentation cases in which 
proprioceptive sensory nerves are damaged due to neuropathy (25, 59), and can also be 
associated with many diseases including multiple sclerosis (60), spinal cord injury (61), diabetes 
mellitus (62) and other degenerative diseases (30). Humans with proprioception dysfunction 
typically have deficits in motor planning, motor control, grading movement and postural 
stability. While previous publications covering motor control/learning as well as rehabilitation 
have been obtained from deafferentated patients (63-65), a human-based in vitro system would 
constitute a valuable phenotypic model for this sensorimotor circuit. The in vitro system reported 
in this study using a well-defined serum-free medium provides a platform for the dissection of 
the physiological/molecular/developmental mechanism and regulation of this mechanosensory 
system. The human nature of this biological system makes it more relevant and amenable to the 
study of neurological and/or muscular disease modeling, drug discovery and regenerative 
medicine. 
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Materials and Methods 
 
DETA Surface Modification Glass coverslips (6661F52, 22x22 mm No. 1; Thomas Scientific, 
Swedesboro, NJ, USA) were cleaned using HCl/methanol (1:1) for a minimum of 2 hours, rinsed 
with water, soaked in concentrated H2SO4 for at least 2 hours and rinsed with water. The 
coverslips were then boiled in nanopure water and oven dried. The 
trimethoxysilylpropyldiethylenetri-amine (DETA, T2910KG; United Chemical Technologies 
Inc., Bristol, PA, USA) film was formed by the reaction of the cleaned surfaces with a 0.1% 
(v/v) mixture of the organosilane in freshly distilled toluene (T2904; Fisher, Suwanne, GA, 
USA). The DETA coated coverslips were heated to ~80oC, cooled to room temperature (RT), 
rinsed with toluene, reheated to approximately 80oC, and then cured for at least 2 hours at 
110oC. Surfaces were characterized by contact angle and X-ray photoelectron spectroscopy as 
previously described (39, 66, 67).  
Induction of intrafusal fibers from human satellite cells 
 
 Human skeletal muscle stem cells (hSKM SCs)/progenitors were isolated, proliferated and 
differentiated as described in Thorrez et al. (68). Briefly, the primary human skeletal muscle 
cells (hSKMs) were isolated by needle biopsy (69) and expanded in the myoblast growth 
medium (MGM; SkGM (Cambrex Bio Science, Walkersville, MD) plus 15% (v/v) fetal bovine 
serum. Biopsies were performed on adult volunteers according to procedures approved by the 
Institutional Clinical Review Board of the Miriam Hospital. Cell preparations averaged 70% 
myogenic content based on desmin-positive staining (70).  
To induce intrafusal fibers from these hSKM SCs, a unique protocol was developed in this study. 
For each culture, hSKM SCs/progenitors with about 20 doubling times were plated on DETA 
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coverslips at a density of 100 cells/mm2 in hSKM Growth Medium (Lonza, CC-3160) and fed 
every 2 days by changing the entire medium until confluency. Myoblast fusion was then induced 
by switching to the differentiation medium 1(36) (high-glucose DMEM (Invitrogen, Carlsbad, 
CA) supplemented with Insulin (10 μg/ml), bovine serum albumin (BSA) (50 μg/ml), Epidermal 
Growth Factor (10 ng/ml) and Gentamicin (50 μg/ml)). For intrafusal fiber induction, Neuregulin 
(10 ng/ml), Laminin (10 ng/ml) and Agrin (10 ng/ml) were added to the differentiation medium 
on day 0, day 4 or day 7 after the initiation of differentiation. The cells were fed every 2 days by 
changing half of the medium. Four days after differentiation initiation, the medium was switched 
to the co-culture medium or medium 2 (Table 2). The cells were fed once using the same 
medium 2 days later by changing half of the medium. Thereafter, the cultures were fed every 2 
days using NBactive4 (Brain Bits, Nb4-500) by replacing half of the medium. 
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Table 2: Composition of Enriched Co-culture Media (Medium 2) 
Component Full Name Concentration Company Catalog Number 
Neurobasal 
/Neurobasal 
A 
  Invitrogen 10888/21103 
B27 (50X)  1X Invitrogen 17504-044 
Glutamax 
(100X) 
 1X Invitrogen 35050 
rhNRG Neregulin 1-β1 
EGF domain 
100 ng/ml R&D 396-GF/CF 
RHβ-NGF Nerve Growth 
Factor 
100 ng/ml R&D 256-GF/CF 
GDNF Glial-derived 
growth factor 
10 ng/ml Cell Sciences CRG400B 
BDNF Brain-derived 
growth factor 
20 ng/ml Cell Sciences CRB600B 
Shh Sonic 
Hedgehog, N-
terminal 
peptide 
50 ng/ml R&D 1845-SH-025 
RA Retinoic Acid 0.1 µM Sigma R2625 
IGF-1 Insulin-like 
Growth Factor 
10 ng/ml PeproTech 100-11 
cAMP Adenosine 
3’,5’-cyclic 
Monophosphat
e 
1 µM Sigma A9501 
CNTF Ciliary 
Neurotrophic 
Factor 
5 ng/ml Invitrogen CRC400A 
NT-3 Neurotrophin-3 20 ng/ml Invitrogen CRN500B 
NT-4 Neurotrophin-4 20 ng/ml Cell Sciences CRN501B 
Vitronectin  100 ng/ml Sigma V8379 
Laminin Mouse Laminin 4 µg/ml Invitrogen 23017-015 
G5 (100X)  1X Invitrogen 17503-012 
Agrin  100 ng/ml R&D 550-AG-100 
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Co-culture of human sensory neurons with human intrafusal fibers  
 
Co-cultures were established according to the procedures depicted in Figure 8. Human sensory 
neurons (hSNs) were differentiated from human neural progenitor cells, STEMEZTMhNP1 
(Neuromics, Edina, Minnesota) as described in Guo et al. (37). Neuromics’ product information 
states that their cells can be expanded through 10 passages before any genotypic monitoring is 
necessary (http://www.neuromics.com/). In this study, passage 9 or 10 cells were used. Briefly, 
hNP1 cells in the growth phase were manually dissociated and replated onto glass coverslips pre-
coated with DETA, followed by Polyornathine/Laminin/Fibronectin (71), at a density of 400 
cells/mm2 . The cells were expanded in the proliferation medium for 2 to 3 days to achieve 
~90% confluence before induction. To initiate sensory neuron differentiation, the medium was 
replaced with KSR medium which contained 10 µM SB43152 (Tocris, Cat 1614) and 500 ng/ml 
Noggin (R&D, Cat 6057-NG-025). To feed the cells during differentiation, the medium was 
replaced and gradually switched from KSR medium (ThermoFisher, Cat 10828028) to N2B 
medium (NeuralStem Inc) according to the following schedule: day 0 (100%KSR, 0% NB), day 
2 (75% KSR, 25% N2B), day 4 (50% KSR, 50% N2B), day 6 (25% KSR, 75% N2B), days 8 & 
10 (0% KSR, 100% N2B). However, the content of SB43152and Noggin (10 µM and 500 ng/ml, 
respectively) remained constant throughout the procedure. Starting with day 12, the cells were 
fed with a differentiation medium by changing 1/3 of the medium every 2 days. After 14 days of 
differentiation, SNs were harvested by trypsinization and added to the muscle culture at a density 
of 75 cells/mm2 , timed so the muscle culture was on day 4 of differentiation and right after it 
had been switched to co-culture medium. 
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Figure 8: Schematic diagram of the culture protocol and timeline. 
 
Immunocytochemistry and microscopy  
 
Cultures were analyzed with immunocytochemistry and microscopy as described before (37, 38). 
Cells on the DETA coverslips were fixed utilizing freshly prepared 4% paraformaldehyde in 
PBS for 15 min. Cells were then washed twice in Phosphate Buffered Saline (PBS) (pH 7.2, w/o 
Mg2+ , Ca2+) for 10 min at room temperature and then permeabilized with 0.1% triton X-
100/PBS for 15 min. Non-specific binding sites were blocked using Blocking Buffer (5% 
Donkey serum plus 0.5% BSA in PBS) for 45 min at room temperature. Cells were then 
incubated with primary antibodies overnight at 4 °C. After being washed with PBS 3x10 min, the 
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cells were then incubated with secondary antibodies for 2.5 hours at room temperature. The cells 
were again washed with PBS 3x for 10 min and mounted utilizing Vectashield with 4'-6- 
Diamidino-2-Phenylindole (DAPI) (Vector laboratories, Inc.). Primary antibodies used in this 
study included: Goat-anti-Peripherin (Santa Cruz Biotech, 1:25), Rabbit-anti-MHC H-300 (Santa 
Cruz, 1:200), Goat-anti-PICK1 (Santa Cruz, 1:200), Mouse-anti-Neurofilament (Sigma, 1:1000), 
Rabbit-anti-Egr3 (Santa Cruz, 1:100), erbB2-℗-Alexa488 (Millipore, 1:250). The monoclonal 
antibody against slow tonic muscle heavy chain (S46, 1:10) was obtained from the 
Developmental Studies Hybridoma Bank which is under the auspices of the NICHD and 
maintained by the University of Iowa. Phalloidin-568 (Life Technologies, 1:40) was included 
during the secondary antibody incubation. The monoclonal antibody against cardiac muscle 
heavy chain BA-G5 was produced as described in Rumsey et al.(34). Secondary antibodies 
include: Donkey-anti-Mouse-568 (Invitrogen, 1:250), Donkey-anti-Rabbit-488 (Invitrogen, 
1:250), and Donkey-anti-Rabbit-568 (Invitrogen, 1:250) Donkey-anti-Gt-488 (Invitrogen, 
1:250). All antibodies were diluted in Blocking Buffer. 
Electrophysiological recording 
 
 Electrophysiological properties of human intrafusal fibers were investigated after ~10 days of 
co-culture with human sensory neurons utilizing whole-cell patch-clamp recording techniques 
(67). The recordings were performed in a recording chamber located on the stage of a Zeiss 
Axioscope 2FS Plus upright microscope (72). Intrafusal fibers were identified visually under an 
infrared DIC-video microscope by their typical bag fiber morphology. Patch pipettes, with a 
resistance of 6-10 MΩ, were made from borosilicate glass (BF 150-86-10; Sutter, Novato, CA) 
with a Sutter P97 pipette puller (Sutter Instrument Company). Current-clamp and voltage-clamp 
recordings were made utilizing a Multiclamp 700A amplifier (Axon, Union City, CA). 
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According to the standard protocol that has been used routinely (67, 73, 74), the pipette 
(intracellular) solution contained (in mM) Kgluconate 140, MgCl2 2, Na2ATP 2, 
Phosphocreatine 5, Phosphocreatine kinase 2.4 mg and Hepes 10; pH 7.2. After the formation of 
a giga ohm seal and membrane puncture, the cell capacitance was compensated. The series 
resistance was typically <23 MΩ, and it was compensated 60% using the amplifier circuitry. 
Signals were filtered at 3 kHz and sampled at 20 k Hz using a Digidata 1322A interface (Axon 
instrument). Data recording and analysis were performed with pClamp8 software (Axon 
instrument). Membrane potentials were corrected by the subtraction of a 15 mV tip potential, 
which is the liquid junction potential between intracellular solution and extracellular solution, 
was calculated using Axon’s pClamp8 program, and it is within the normal range of junction 
potential for patch clamp (10~20 mV) (75). Membrane resistance and capacitance were 
calculated using 50 ms voltage steps from –85 to – 95 mV without any whole-cell or series 
resistance compensation. The resting membrane potential and depolarization-evoked action 
potentials were recorded in current-clamp mode. Depolarization-evoked inward and outward 
currents were examined in voltage-clamp mode. Single APs were elicited by a brief saturated 
depolarization current. 
Quantification  
 
For the quantification of bag fiber induction under phase microscopy, a minimum of 10 random 
fields were imaged under phase microscopy. The number of bag fibers out of the total number of 
myotubes was quantified for each experimental condition and compared to the control. At least 3 
independent cultures were analyzed for each condition. Statistical analysis by T-Test (one tail, 
two samples with unequal variance) was performed to compare differences between samples and 
P<0.05 was considered significantly different.  
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CHAPTER THREE: FUNCTIONAL ANALYSIS OF HUMAN INTRAFUSAL FIBER 
INNERVATION BY HUMAN 𝜞-MOTONEURONS 
 
The work in this chapter was published as listed below under a Creative Commons license and 
therefore does not require copyright permission. 
Colón A, Guo X, Akanda N, Cai Y, Hickman JJ. Functional analysis of human intrafusal fiber 
innervation by human γ-motoneurons. Sci Rep. 2017 Dec 8;7(1):17202. 
A.C. performed preparations of all muscle and some motoneuron cultures, all 
immunocytochemistry, some experimental design and most data analysis. X.G. performed 
experimental design, data analysis, set data interpretation guidelines and helped with 
manuscript revision. N.A. performed all electrophysiology recordings. Y.C. performed most 
of the motoneuron culture. J.J.H. designed the experiments and directed the work as well as 
edited the manuscript until it was in its final form. 
 
Introduction 
 
There has been a recent emphasis on the development of in vitro  “human-on-a-chip” systems for 
use in drug discovery studies as well as basic cell biology investigations. While animal models 
have been the standard for disease and drug evaluation, many of the effects seen in these 
models are incongruent with the effects seen in humans. Furthermore, various organizations 
have restricted the use of animal models for ethical considerations. To avoid these 
difficulties, in vitro systems that integrate human cell culture with bio-
microelectromechanical systems (BioMEMS) devices are being investigated for their ability 
to recapitulate functional human organ systems(1, 8, 9, 76-80). The high content analysis 
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capabilities, reproducibility, ethical considerations, and biological flexibility with relevant 
cell types have increased the demand for realistic functional in vitro systems. The 
neuromuscular reflex arc is a highly complex biological circuit, where the actuation segment 
has been successfully evaluated using in vitro systems(13, 14, 37, 81-83). We have previously 
shown functional neuromuscular junction formation in vitro for both animal and human cells 
on a non-biological substrate(13, 37). We have also demonstrated the fundamental sensory 
portion of the arc by animal and human sensory neuron innervation of intrafusal fibers (14, 
15). Further elaboration of this system, by incorporating additional sensory components, 
allows for a more accurate recapitulation of in vivo functionality and serves as a better 
representative platform for investigating prosthetic design, neuromuscular diseases and 
understanding the mechanism of action for relevant drugs and their targets(84, 85). 
The stretch reflex arc is the physiological system that regulates skeletal muscle movement and 
tension. This arc can be broken down into two primary components: the efferent and afferent 
domains. The efferent domain regulates mechanical actuation, muscle tension and relaxation 
through extrafusal fibers(86). The regulatory control of tension and contraction is mediated by 
innervating α-motoneurons. Embedded within the extrafusal fiber tissue are muscle spindles, 
the sensory organ for afferent (sensory) signals to regulate muscle function(86). The spindles 
are composed of intrafusal fibers encapsulated in collagen and innervated by both sensory and 
gamma-motoneurons (γ-MNs)(86-88). The primary role of intrafusal fibers is the detection of 
the magnitude and speed of stretch or flexion of the muscle and the position of the limbs, or 
proprioception(86, 87). Upon a change in muscle tension, the muscle spindles send signals 
through afferent sensory neurons which are relayed to neurons within the spinal cord. 
Motoneurons receiving afferent information can then signal to intrafusal or extrafusal fibers to 
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relax or contract in response to sensory input(86). With the afferent sensory feedback, the 
reflex arc acts as an automated closed loop so that voluntary movement can be achieved 
accurately and properly. 
Several types of neurons innervate both the extrafusal and intrafusal fibers of the muscle 
tissue. The extrafusal fibers are primarily innervated by α motoneurons while intrafusal fibers 
are innervated by both sensory neurons and γ-MNs(86). The Type Ia sensory neurons 
innervate the intrafusal fibers with annulospiral wrappings around the equatorial region and 
Type II sensory neurons employ flower spray endings towards the peripheral ends of the fiber. 
γ-MNs innervate the peripheral ends of the intrafusal fibers via flower-spray endings as well. 
The peripheral ends of the intrafusal fibers slowly relax or contract under the control of γ -
MNs. These γ-MNs modulate the tension, sensitivity, and length of the intrafusal fibers so 
muscle spindles can maintain constant sensitivity during dynamic muscle action and prevent 
overextension, which can lead to undue stress on the muscle as well as tendon and joint 
damage(87). Unlike α motoneurons, γ-MNs do not directly induce muscle tissue contraction 
or relaxation but modulate the sensitivity of the muscle spindle instead(86), which then 
modifies the activity of α-motoneurons (α-MN) and subsequent muscle contraction. Human-
based in vitro models for the innervation of extrafusal fibers by α-MNs and intrafusal fibers 
by proprioceptive sensory neurons have been established, but an in vitro model for the 
innervation of intrafusal fibers by γ-MNs has yet to be developed, despite being crucial for 
proper function of the neuromuscular system. Development and incorporation of this γ -
motoneuron - intrafusal fiber system into the reflex arc would provide a better platform for the 
study of neuromuscular development, prosthetic design, relevant diseases and the evaluation 
of potential drug candidates. 
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Investigations surrounding γ-MN interactions have been sparse due to the nature of the cell 
types involved, and the lack of in vitro studies demonstrating this particular cellular 
interaction, especially with human cells. Although γ-MNs have a specific function in the 
neuromuscular system, their developmental similarity to α-MNs has made it difficult to 
identify them for study. γ-MNs originate in the ventral spinal cord along with three subtypes 
of α-MNs(86, 87). Recently, molecular markers have become available for identifying γ-MNs 
in co-culture with α-MNs from murine tissue(89-94). However, functional data of postnatal in 
vitro γ-MNs has yet to be observed and no human systems have been studied. 
Utilization of human reflex arc test platforms with the inclusion of γ-MNs could allow for 
more appropriate analysis of neuromuscular diseases, particularly in relation to proprioceptive 
function. This is specifically applicable for Spinal Muscular Atrophy (SMA) research. The 
mechanism for SMA progression in murine models indicated a difference in motoneuron 
subtype (α versus γ) survival rates compared to analysis of human cells(95). These data imply 
that animal models may be insufficient to recapitulate the human form of the disease and 
more accurate, reproducible, and modular models are needed to fully understand the 
mechanisms of disease onset and progression. There is also a distinct possibility that this 
circuit can be involved in neuropathic pain in some cases(96) and a model system that could 
investigate this possibility should significantly advance our understandings in this field. In 
this study, we aimed to develop a de novo defined human-based functional in vitro fusimotor 
system in which the innervation of intrafusal fibers by γ-MNs was evaluated by both 
immunocytochemical and electrophysiological approaches. 
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Results 
 
Morphological analysis 
 
Human intrafusal fibers were co-cultured with human motoneurons (MNs) on 
trimethoxysilylpropyldiethylenetriamine (DETA) coated glass coverslips in serum-free 
medium. This surface modification has been used as a means of providing a surface amenable 
for the proliferation and maturation of an array of cell types for long term experimentation(7, 
13-15, 34, 36, 37, 79, 81, 82, 97-102) Figure 9 indicates the protocol for cell expansion and 
differentiation for developing the co-culture and more detail can be found in Guo et al.(15) 
and Guo et al.(36). Cellular proliferation and differentiation of intrafusal fibers and neurons 
were temporally monitored via phase contrast microscopy and assessed via morphological 
analysis as shown in Figure 10. Intrafusal fibers and neurons were identified in the culture by 
their unique morphological features. Chain fibers have long segments of aligned nuclei in the 
equatorial region and bag fibers have a large cluster of nuclei in the center of the fiber, which 
tapers down to thin myotube endings used to anchor both ends of the elongated cell within the 
spindle in vivo(44). Phase contrast images demonstrated both chain and bag morphologies of 
intrafusal fibers. Direct physical contacts observed morphologically between intrafusal fibers 
and neurons indicated possible intrafusal fiber innervation by MNs (Figure 10 F-G). 
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Figure 9: The cell culture scheme for the differentiation of the human intrafusal fibers derived 
from satellite cells. MNs added on day 10 of the culture were subjected to 2–10 DIV 
differentiation. 
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Figure 10: Phase contrast analysis of the human skeletal muscle and motoneurons. (A) Human 
muscle at 4 DIV. (B) Human MNs at 4 DIV. (C and D) Human muscle cultured 
without (C) and with (D) MNs at 17 DIV. (E and F) Morphological confirmation of intrafusal 
fibers in both muscle only (E) and muscle and MNs co-cultures (F). (G) An enlarged view of 
image F to demonstrate the contacts of axon terminals with intrafusal fibers. Intrafusal fibers 
are indicated with arrows and MNs are indicated with black arrowheads. Neuromuscular 
contacts are indicated with white arrowheads. Black scale bars are 500 µM. White scale bars 
are 50 µM. 
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Immunocytochemical analysis 
 
After maturation, at approximately day 15 of the human muscle and MN co-culture, cells 
were immunostained utilizing the molecular markers for both intrafusal fibers and γ-MNs 
(Table 3). The general marker used to identify muscle fibers in the cultures was All myosin 
heavy chain (AllMyHC). Neurofilament, a neuronal cytoskeleton marker, was used to non-
specifically identify neurons. Intrafusal fibers were identified using pERB2 and EGR3. ErbB2 
is a receptor tyrosine kinase for neuregulin, a molecule released by neurons as part of the 
intrafusal induction mechanism during differentiation(103). Upon the binding of neuregulin to 
ERB2, the receptor becomes phosphorylated (pErbB2)(104), leading to an increase in the 
transcription factor EGR3, which initiates the expression of genes for intrafusal 
differentiation(105). Immunocytochemistry indicated positive identification of both bag and 
chain intrafusal fibers (Figure 11). 
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Table 3: Listing of primary antibodies used to characterize γ-motoneurons, intrafusal fibers 
and the co-cultures. 
Antibody Target Host 
Species 
Dilution/ 
Concentration 
Source Catalog 
Number 
All 
MyHC 
All muscle Mouse 1:10 Developmental 
studies hybridoma 
bank 
A4. 1025 
Phospho-
erbB2 
Intrafusal 
fibers, 
activated 
NRG 
receptors 
Rabbit 2 µg/ml Millipore 06-229 
EGR3 Intrafusal 
fibers, 
transcription 
factor 
Rabbit 1:100 Santa Cruz 
Biotechnology 
SC-191 
Errγ γ-MNs Mouse 1:100 Perseus 
Proteomics 
PD-
H6812-00 
α-
Bungaro-
toxin 
Acetylcholine 
receptors 
N/A 1:100 Thermo Fisher B13422 
Neurofila
ment 
Neuronal 
cytoskeleton 
Chicken 1:1000 Millipore AB5539 
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Figure 11: Immunocytochemical analysis of intrafusal fibers and γ-MNs. (A and B) Intrafusal 
fibers were identified with the antibodies against EGR3 (A) and pErbB2 (B). Myotubes were 
visualized with the antibody against All Myosin Heavy Chains, and nuclei were identified by 
DAPI (A and B). A sample image of a chain fiber is shown in panel A and bag fiber in panel 
B. (C)Motoneuron cultures were stained with Neurofilament and γ-MNs were additionally 
stained with an antibody against ERRγ. Scale bars are 50 µM . 
Very few markers have been reported for γ-MNs, but ERRγ (95) was found to be the most 
robust. Other markers were evaluated, including Wnt7a (marker for γ -MNs) and NeuN 
(marker for α-MNs), but did not have as robust and repeatable of a signal as ERRγ (Figure 
11). γ-MNs were recognized by positive immunostaining for ERRγ and the axonal terminals 
were visualized with neurofilament (Figure 12 A). Since the cultures used have a mixed 
population, γ-MNs were quantified in a motoneuron preparation and it was found to have 
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3.63% γ-MNs (±0.86%). Previous work has shown these cultures contain about 20% of 
motoneurons(101) so the MN culture consisted of about 18% γ-MNs in the culture. Recent 
literature from in vivo animal studies has also shown that γ-MN innervation of intrafusal 
fibers is an acetylcholine (ACh)-based neuromuscular interaction(106). In order to detect the 
possible innervation of intrafusal fibers by γ-MNs in the co-culture, intrafusal fibers were 
visualized by fluorescently-labeled bungarotoxin (BTX), a toxin that specifically binds to 
ACh receptors (Fig. 4). The close apposition of γ-MN axonal terminals or soma with the ACh 
receptor -positive intrafusal fibers were frequently observed under high definition confocal 
microscopy, demonstrating immunocytochemical evidence for the potential innervation of 
intrafusal fibers by γ-MNs. These interactions were quantified as 53.4% (±7.59%) of all 
neuromuscular appositions. Considering the low percentage of γ-MNs in the motoneuron only 
culture, interactions between intrafusal fibers and γ-MNs appear to be enhanced over 
interactions between intrafusal fibers and other neuron types in the culture. This may imply a 
selective mechanism to promote NMJs between γ-MNs and intrafusal fibers. 
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Figure 12: Immunocytochemical analysis of motoneuron only cultures. Markers for Wnt7a 
(Abcam ab100792) (A) NeuN (Millipore MAB377) (B) and ERRGamma (C) 
immunocytochemistry in motoneuron only controls. Scale bars are 50 µM. 
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Figure 13: Immunocytochemical analysis of intrafusal fibers and motoneurons co-cultures. 
(A) Co-cultures were stained with Bungarotoxin (BTX), Neurofilament, and ERRγ. (B) High 
definition image for the boxed area in (B) indicates a close apposition of an axonal terminal 
from a γ-MN with BTX-488 patches (white arrow). Scale bars are 50 µM. 
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RNA expression analysis 
 
Immunocytochemistry results for γ-MN percentage in the MN cultures were confirmed by 
quantitative PCR analysis. RNA expression of ERRγ was examined in human motoneuron 
cultures, utilizing the undifferentiated neural progenitors (human spinal cord stem cells, or 
SCSCs) as the control. There was found to be a 5.3 fold increase in ERRγ expression in 
differentiated human motoneurons compared to the control (Figure 14). This confirmed the 
increase in expression levels of the γ-MN specific marker ERRγ in the immunocytochemical 
data, demonstrating the presence of γ-MNs in the heterogeneous culture. 
 
Figure 14: Quantitative PCR: Quantification of ERRγ in the motoneuron culture compared to 
that in their undifferentiated precursors, human SCSCs 
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Electrophysiological analysis 
 
The immunocytochemical evidence strongly suggested that the stimulation of γ-MNs would 
lead to electrophysiological activity in the intrafusal fibers. In order to determine if the 
innervations identified immunocytochemically were functional, patch-clamp 
electrophysiological recordings were performed on intrafusal fibers (15–30 days in 
vitro (DIV)). Glutamate is an excitatory neurotransmitter that has been previously used to 
stimulate neurons in co-cultures with muscle without directly initiating myotube 
contraction(13). The electrophysiological response to the addition of glutamate, both with and 
without MNs in the culture, was recorded from intrafusal fibers, identified by their 
morphological characteristics, in the co-culture (Figure 15 A,B). Theoretically, the intrafusal 
fiber, if innervated, should be excited upon glutamate addition, while those not innervated 
should not be affected. As indicated, bursts of myotube action potentials (APs) were induced 
in multiple intrafusal fibers upon glutamate addition, suggesting innervation by γ-MNs 
(Figure 15 C). To confirm that the increased AP firing was initiated by ACh-mediated 
innervation, a blocking agent for ACh mediated synaptic transmission, curare, was applied 
after increased firing was initiated by glutamate treatment(13). Immediate cessation of 
electrophysiological activity was observed (Figure 15 D). This demonstrated the functional 
innervation of the intrafusal fibers by γ-MNs. As a control, the same experiment was 
performed on intrafusal fibers in the absence of MNs where no significant change of activity 
was detected. Quantification of the co-cultures indicated that 28 out of 34 intrafusal fibers 
were excited upon glutamate addition, while only 1 out of 23 muscle-only controls were 
excited (p value = 0.2.17e-9) (Figure 16). The few intrafusal fibers not excited in the co-
culture may not have been innervated, resulting in a lack of response to MN activity. This 
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data confirms not only the formation of functional synapses but also demonstrates a high 
percentage of γ-MN innervation of the intrafusal fibers under these co-culture conditions. 
 
 
Figure 15: Patch-clamp analysis of intrafusal fibers. (A,B) Representative bright field 
microscopy of patched intrafusal cells in motoneuron-muscle co-cultures (A) and muscle only 
controls (B). (C,D) Gap-free recordings from patched intrafusal fibers in motoneuron–muscle 
co-cultures (C) and muscle only controls (D). Addition of glutamate (marked with green 
arrows) in the co-culture elicited increased activity and addition of curare (marked with red 
arrow) terminated activity (C) but no activity change was induced by either of them in 
intrafusal fibers in the muscle culture alone (D). 
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Figure 16: Statistical analysis. Percentages of glutamate responding and glutamate 
nonresponding intrafusal fibers in muscle-motoneuron co-culture conditions and muscle only 
conditions. P value = 2.17e-9. 
Discussion 
 
We have developed a human-based in vitro fusimotor system in which functional innervation 
of intrafusal fibers by γ-MNs was demonstrated by morphological, immunocytochemical and 
electrophysiological analysis. Neither the culture of human γ-MNs nor their innervation by 
intrafusal fibers has previously been shown in vitro. The recapitulation of the spindle 
fusimotor circuit in vitro with human cells provides a defined model to investigate the 
physiology of this circuit, which is otherwise extremely difficult to observe for human 
systems. The use of MNs and muscle derived from iPSCs also offers the possibility for their 
incorporation into human-on-a-chip systems designed for the investigation of patient specific 
neuromuscular diseases and deficits. 
The functional sensory circuits, especially human based systems, have previously not been 
extensively investigated in vitro and γ-MN identification and functional innervation had not 
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been demonstrated with human cells at all. Here, a co-culture of human intrafusal fibers and 
human MNs was established to evaluate the interactions between these two important cell 
types from the sensory portion of the reflex arc. Initial morphological analysis via phase 
contrast microscopy indicated the two cell types were compatible in a serum-free defined 
system and formed close physical contacts suggesting synaptic interactions. 
Immunocytochemical analysis confirmed the identity of the cell types in these intercellular 
interactions. Intrafusal fibers stained positive for pERB2 and EGR3, while the γ-MNs were 
identified by immunostaining with a γ-MN specific marker ERRγ(87, 89, 93). 
Electrophysiological analysis confirmed functional interactions between the γ-MNs and 
intrafusal fibers. γ-MNs were stimulated using the neurotransmitter glutamate. The majority 
of intrafusal fibers in co-culture demonstrated increased excitation upon the application of 
glutamate (28 out of 34), while only one intrafusal fiber in the monoculture responded. 
Furthermore, the glutamate-induced responses were terminated by the application of curare, a 
competitive antagonist of acetylcholine receptors. These data indicate functional innervation 
of human intrafusal fibers by human γ-MNs in our defined in vitro system. 
It should be pointed out that a single intrafusal fiber in monoculture conditions exhibited AP 
firing upon exposure to glutamate. The presence of glutamate receptors on muscle fibers is 
known and has been researched(107, 108). Multiple mechanisms have been proposed 
regarding the function of glutamate receptors in muscle tissue, but none of which correspond 
to direct action potential generation(109-114). Actually, a similar response was recorded from 
another intrafusal fiber in a muscle-only culture by adding media instead of glutamate (data 
not shown), indicating the addition event itself could non-specifically induce muscle 
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excitation, although very rarely. To further confirm the muscle was not directly excited by 
glutamate in our system, glutamate dosage experiments (data not shown) were performed on 
muscle only cultures to evaluate the responsiveness of intrafusal fibers to increasing 
concentrations of glutamate. The lack of glutamate mediated electrical activity in these 
cultures, even at concentrations far higher than used in experiments reported here, 
demonstrates the lack of direct response to glutamate. This evidence confirms that the single 
cell responsive to glutamate was not the result of a glutamate induced electrophysiological  
mechanism in this human model. 
Study of the entire functional reflex arc is essential to understand and further investigate many 
neuromuscular disorders, predominantly Amyotrophic Lateral Sclerosis (ALS) and Spinal 
Muscular Atrophy (SMA). In both reports the sparing of γ-MNs were reported in mice models 
as well as peripheral neuropathies(95, 115). Most existing in vitro systems used to study these 
diseases only investigate the motor perspective of neuromuscular interactions. However, 
utilization and especially integration of sensory components is essential to investigate 
complicated neuromuscular diseases by the inclusion of afferent mechanisms. Additionally, 
the sensory portion of the reflex arc has been of interest to the field of pain research(96). Drug 
discovery has been moving towards more repeatable and high-throughput organ-on-a-chip in 
vitro systems recently for use in preclinical compound evaluation to improve drug discovery 
efficiency(1, 8, 9, 76-80). These systems provide a highly controllable and repeatable 
platform that can be tailored to more human-specific diseases by utilizing patient-derived 
iPSCs. Incorporation of γ-MN and intrafusal interactions to such systems will allow for a 
more complete and refined model for simulating neuromuscular diseases and testing a 
multitude of drug response variables. 
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Materials and Methods 
 
Surface modification 
 
18 mm round glass coverslips (VWR, 48380-046) were cleaned and functionalized by 
exposure to an oxygen plasma generated by a Harrick plasma cleaner (model PDC-32G) 
utilizing high purity oxygen gas. The surfaces were then submersed in a reaction solution of 
1% v/v of trimethoxysilylpropyldiethylenetriamine (DETA, United Chemical Technologies, 
Inc., T2910-KG) in dry toluene (VWR, BDH1151-4LG) and heated to just below the boiling 
point of toluene over a period of 30 minutes. The reaction vessel was removed from heat and 
allowed to cool for 30 minutes, and then rinsed in 3 serial toluene baths. Next, the surfaces 
were placed in dry toluene and heated to just below the boiling point of toluene over a period 
of 30 minutes. After the second heating step, the surfaces were cured in an oven at 
approximately 110 °C overnight (~15 hr). Derivatized surfaces were characterized by contact 
angle goniometry, with a 5 µL droplet of water, and by X-ray photoelectron spectroscopy 
using a Thermo Scientific ESCALAB 220i-XL instrument with aluminum Kα X-rays and a 
90° take-off angle(97, 98). 
Cell culture 
 
Human intrafusal fibers were differentiated from human satellite cells provided as a gift from 
Dr. Herman Vandenburgh. Human skeletal muscle stem cells (hSKM SCs)/progenitors were 
isolated and proliferated as described in Thorrez et al.(68) Briefly, the primary human skeletal 
muscle cells (hSKMs) were isolated by needle biopsy(116) and expanded in the myoblast 
growth medium (MGM; SkGM (Cambrex Bio Science, Walkersville, MD) plus 15% (v/v) 
fetal bovine serum. Biopsies were performed on adult volunteers according to procedures 
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approved by the Institutional Clinical Review Board of the Miriam Hospital and were 
performed in accordance with the relevant guidelines and regulations. All samples, from the 
study participation and publication of images, were obtained with informed consent and de-
identified before being sent to UCF. Cell preparations averaged 70% myogenic content  based 
on desmin-positive staining(117). The differentiation protocol was adapted from our protocol 
for extrafusal fiber differentiation by inclusion of specific factors to facilitate intrafusal 
differentiation(15). Specifically, thawed satellite cells from liquid nitrogen were plated onto 
glass coverslips at a density of 100 cells per mm2. The cells were given a whole medium 
change of human skeletal growth medium every two days until confluent. Upon confluence, 
the medium was fully switched to differentiation 1 medium (DMEM (Invitrogen 11775-040), 
Insulin (Sigma I9278) at 10 µg/ml, BSA (Sigma A9418) at 500 µg/ml, and EGF ( Invitrogen 
13247-051) at 10 ng/ml)(36) and fed every 2 days for 4 days. At this point, the medium was 
switched to differentiation 2 medium (described in detail in Guo et al.(15)) and MNs were 
added to co-cultures at 50 cells per mm2. The cells were fed every two days with 
differentiation 2 medium and maintained for four days. After this point, the medium was 
given a half change with NBActive4 differentiation medium. The cells were maintained in 
this medium for the remainder of the culture and fed every two days until 15–30 DIV total 
when they were analyzed via electrophysiology or fixed for immunocytochemical analysis. 
Human Motoneurons were differentiated from spinal cord stem cells (SCSCs) NSI566RSC 
according to a previous report(37). Specifically, thawed SCSC cells (0.5 E6) from liquid 
nitrogen were plated onto a T-25 cell culture flask coated with Poly-D-Lysine. The cells were 
supplemented with bFGF every day and fed every other day with N2B medium. Upon 
confluence, the cells were trypsinized with 0.05% Trypsin and the reaction was inhibited with 
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the addition of 0.2% Trypsin inhibitor (final 0.05%). The cells were replated onto a permanox 
dish (Diameter 60 mm) coated with Poly-D-Lysine and fibronectin. Cells were initially plated 
in priming medium and fed on day 2 of culture with a half change of medium. On day 4 the 
medium was half changed with human MN medium. The cells were maintained in the 
permanox dish for about 10 days. At this point cells were again trypsinized and purified via an 
Optiprep concentration gradient (Optiprep diluted to 30% [v/v] utilizing Neurobasal with and 
without phenol red (ThermoFisher Cat#21103-049 and Cat#12348-017, respectively) and then 
made to 9.5, 7.0, 6.0, and 5.5% for fractions 1–4, bottom to top sequentially [v/v] in 
Neurobasal, with fractions 1 and 3 containing phenol red and fractions 2 and 4 lacking phenol 
red for optimizing visualization of the fractions). The cells were plated into DETA coated 
glass coverslips for less than 10 days before being trypsinized (as described above) and 
replated onto either muscle cultures or control DETA coated glass coverslips. At this point the 
neurons either underwent exposure to intrafusal differentiation media (co-cultures) or were 
maintained in human MN medium (monocultures). 
Immunocytochemistry 
 
Cells on coverslips were fixed with 4% paraformaldehyde diluted in PBS solution for 
15 minutes, then rinsed with PBS (phosphate buffered saline) for 5, 10, and 15 minutes and 
stored until staining in PBS. Cells were permeabilized with 0.1% Triton X-100 for 15 minutes 
then incubated for 1–2 hours at room temperature in blocking buffer (5% Donkey serum 
+0.5% BSA in PBS) to prevent nonspecific binding. Fixed and permeabilized cells were 
incubated overnight with primary antibodies (diluted in blocking buffer) at 4 °C. Antibodies 
used and their concentrations are listed in Table 3. The cells were rinsed with PBS for 
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5 minutes, 0.01% Trition X-100 for 10 minutes and PBS for 15 minutes, and then subjected to 
incubation with the secondary antibodies (1:250 diluted in blocking buffer) for 1–2 hours at 
room temperature. The cells were then rinsed with PBS for 5 minutes, 0.01% Trition X -100 
for 10 minutes and PBS for 15 minutes and mounted onto glass slides using ProLong Gold 
Antifade Mountant with DAPI (Thermo FisherP36931) or Vectashield mounting medium for 
fluorescence (Vector laboratories, Burlingame, CA) and imaged using a Zeiss LSM 510 
confocal microscope. 
Quantitative polymerase chain reaction 
 
Human motoneurons and human spinal cord stem cells were harvested for RNA extraction at 
less than 10 days in vitro. The RNA extraction was done utilizing the Aurum™ Total RNA 
Mini Kit (Biorad 7326820). RT-PCR was performed using the iTaq™ Universal SYBR® 
Green One-Step Kit (Biorad 1725150). Reaction volumes was 25 µl total (12.5 µl 2X 
SYBR®Green reaction mix, 0.75 µl forward primer at 10 µM, 0.75 reverse primer at 10 µM, 
1.0 µl iTaq DNA polymerase, 10 ng RNA template, and enough water to fill the remaining 
volume). Reactions were incubated at 50 °C for 10 minutes, 95 °C for 5 minutes, 95 °C for 
10 seconds and 55 °C for 30 seconds cycled 40 times, and underwent melt curve analysis 
(95 °C for 1 minute, 55 °C for 1 minute, and 55 °C to 95 °C for 80 cycles for 10 seconds, 
increasing 0.5 °C each cycle). ERRγ (Forward: 5′-AGGAAAACCTATGGGGAATG-3′; 
Reverse: 5′-GGAGCAAATGAAATGTGGGTG-3′) expression was evaluated along with β-
actin (Forward: 5′-CCCCATTGAACACGGCATTG-3′; Reverse:5′-
ACGACCAGAGGCATACAGG-3′) as a positive control and template free β-actin reactions 
as negative controls. Samples were run in triplicate along with β-actin positive controls and 
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template free negative controls. An MJ mini thermal cycler (Biorad) and Opticon Monitor 
software (Biorad) were used. Expression levels were corrected with β-actin levels. 
Electrophysiology 
 
Whole-cell patch clamp recordings were performed in a recording chamber on the stage of an 
upright microscope (Axioscope FS2, Carl Zeiss, Göttingen, Germany). The patch-clamp 
recording chamber was filled with the same medium as utilized for cell culture. The 
intracellular solution composition was (in mM): K-gluconate 140, NaCl 4, CaCl2 0.5, 
MgCl2 1, EGTA 1, HEPES acid 5, HEPES base 5, Na2ATP 5. Patch pipettes were prepared 
(borosilicate glass, BF150-86-10; Sutter, Novato, CA) with a Sutter P97 pipette puller. Pipette 
resistance was 4–10 MΩ for intracellular patch clamp recordings. Experiments were 
performed with a Multi clamp 700B (Axon Instruments, Foster City, CA, USA) amplifier. 
Signals were filtered at 2 kHz and digitized at 20 kHz with an Axon Digidata 1322 A 
interface. Action potentials were recorded in current-clamp mode under gap free conditions at 
zero holding potential. The series resistance was in the range of 5–10 MΩ and was 
compensated by 60% on-line. Leak currents were subtracted using a standard P/4 protocol. 
Before seals were established on the cells, offset potentials were nulled. Capacitance 
subtraction was used in all recordings. All intrafusal fibers chosen in co-culture conditions 
were in proximity to MNs identified via morphological analysis. To test whether the patched 
intrafusal fiber was innervated, glutamate was added in 30 ul doses of 200 mM to the 
extracellular solution in the vicinity of the patched intrafusal fiber. When excited, the MNs 
would excite innervated muscle fibers and the excitation was recorded. Once repetitive firing 
was consistent, curare was added in 30 ul doses of 500 uM to the extracellular solution.  
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Statistical analysis 
 
The proportion of active intrafusal fibers that showed electrical activity in response to 
glutamate was compared between muscle only and co-cultured conditions by categorizing 
each patched cell as responsive or unresponsive and organized into a contingency table, 
followed by statistical analysis via Fisher’s Exact Test (α = 0.05). 57 cells were patched across 
multiple coverslips and platings. The standard error of the mean for each proportion was 
calculated for the binomial distribution. γ-MN quantification data was taken from 20 view 
fields from each of three separate coverslips spanning over two separate platings. For γ -
motoneuron- intrafusal fiber interaction quantification, two separate co-culture coverslips 
from two separate platings were stained with ERRγ, BTX488, and neurofilament. Intrafusal 
fibers positive for BTX488 staining that had contact with neuronal processes positive for 
neurofilament that lead to an identifiable soma were counted. Standard deviations were 
calculated and expressed as percent error. 
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CHAPTER FOUR: DIFFERENTIAITON OF HUMAN INTRAFUSAL FIBERS FROM 
INDUCRED PLURIPOTENT STEM CELLS 
 
The work in this chapter was submitted for publication as follows. 
Colón, A., Badu-Mensah, A., Guo, X., Goswami, A., Hickman, J.J. Differentiation of intrafusal 
fibers from human induced pluripotent stem cells. ACS Neuroscience. June 14, 2019. 
J.J.H. and A.C. performed the experimental design, A.C. performed the differentiation from 
myoblasts to mature myotubes, all immunocytochemistry, all imaging, executed statistical 
analysis, arranged the figures, and wrote the manuscript. A.B. performed all differentiation of 
iPSCs into myoblasts and provided feedback on the manuscript and experimental design. X.G. 
contributed significantly to the manuscript, experimental design, and data interpretation. A.G. 
provided the DETA modified glass coverslips. J.J.H. directed the work and edited the manuscript 
until it was finalized. 
 
Introduction 
 
Animal models have never been an optimal route for modeling human disease states and 
physiology (1, 76). The differences between human and animal physiology have  often caused 
failures in drug trials, leading to a slow and expensive drug discovery process (76). Furthermore, 
regulatory bodies have been emphasizing more ethical standards for drug discovery, moving 
toward more animal-free designs. As a result, “body-on-a-chip” testing platforms have become a 
major interest to drug companies, research scientists, practicing clinicians, and related regulatory 
bodies. These platforms integrate microelectromechanical systems (MEMS) and specific cell 
types to have functional phenotypic models of single and multi-organ systems. This allows for 
the evaluation of the pathology of specific diseases as well as the response of these specific cells 
54 
 
to drug treatments (77). While several human-based cell lines are available for integration into 
these “body-on-a-chip” systems, there are certain challenges regarding maintenance, 
reproducibility, and clinical relevance for diseases with genetic variances. Induced pluripotent 
stem cells (iPSCs) have found increasing significance in the development of phenotypic models 
for many diseases due to their ease of use, significant clinical relevance and in many cases the 
lack of relevant animal models (11). These cells are obtained from human biopsy or blood 
samples and are treated with defined factors to drive their developmental stage back to 
pluripotency (118). They can then be re-differentiated into multiple cell lineages, allowing for 
the phenotypic evaluation of specific genotypes and their physiological manifestations and drug 
responsiveness. The integration of these cell types into “body-on-a-chip” technology is essential 
for developing testing platforms designed for use in preclinical drug candidate evaluation and 
use in personalized medicine and treatment plan optimization applications.  
The neuromuscular reflex arc is composed of four cell types: motoneurons, sensory neurons, 
extrafusal fibers, and intrafusal fibers. Motoneurons send efferent signals to the contractile 
extrafusal fibers, modulating the contraction, relaxation, and tension of the muscle tissue. 
Embedded in the extrafusal skeletal muscle tissue is the muscle spindle composed of intrafusal 
fibers. The subtypes of intrafusal fibers have distinct morphological characteristics. Bag fibers 
have a large collection of nuclei in the equatorial region with a tapering to each anchoring fiber 
end (44). Chain fibers have a collection of nuclei in close proximity composed of a single row 
with a narrow cytosol (44). The muscle spindle is the sensory organ of muscle tissue and sends 
afferent proprioceptive information to the central nervous system via sensory neurons (44, 88, 
119). Additionally, these muscle spindles can be innervated by gamma motoneurons to aid in 
compensating for muscle length and maintaining spindle sensitivity (86). 
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This multi-cell reflex arc system has been previously evaluated by integrating the cellular 
compounds of the arc with MEMS devices (14-16, 34, 81, 83, 120) to model the complex 
structure and physiology of the neuromuscular reflex arc (5, 7, 13, 14, 99, 121-124). However, 
current technologies have limitations that warrants research improvements and increased 
sophistication of the platforms. One of the most useful hybrid devices is the incorporation of 
extrafusal (7, 13, 99, 123, 125) and intrafusal (14) fibers with silicon cantilever platforms to 
record or activate myofiber function. Recent techniques have used commercially available cell 
lines which can aid in the investigation of basic physiology but fail to address genetic 
components of neuromuscular diseases such as amyotrophic lateral sclerosis (ALS) and spinal 
muscular atrophy (SMA). These diseases have several genetic variants, each of which have 
relatively unique molecular differences (126, 127). Integration of iPSCs into existing cantilever-
based testing platforms would allow for real-time functional investigation of these genetic 
differences and how they influence force output and connectivity aberrations due to specific 
mutations. Motoneurons, (128) sensory neurons, (129) and extrafusal fibers, (130) have each 
been previously derived from iPSCs. However, the differentiation of intrafusal fibers from iPSCs 
is yet to be demonstrated.  
Intrafusal fiber differentiation in vivo is primarily regulated by neuregulin (NRG), a factor 
secreted by sensory neurons during neuromuscular development (16, 35, 40). Once NRG 
interacts with ErbB2 receptors in the undifferentiated myoblasts, this receptor becomes 
phosphorylated (phospho-erbB2 or pErbB2) (16). This phosphorylation leads to the induction of 
intrafusal fiber specific transcription factors, such as Egr3, (16, 35) and the differentiation of 
these myofibers into intrafusal fibers (16, 35). Addition of NRG to in vitro cultures to increase 
activation of this pathway has been previously utilized to increase the amount of intrafusal fibers 
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in both human (15, 16) and rat (34) myoblast cell lines. In this work, NRG supplementation to 
the culture medium was sufficient to drive iPSC-derived myoblasts toward intrafusal fiber 
differentiation. The morphology and ErbB2 phosphorylation levels was evaluated to confirm 
intrafusal fiber identity. Additionally, these cells were grown and differentiated on 
trimethoxysilyspropyldiethylenetriamine (DETA) coated surfaces, a self-assembling monolayer 
compatible with “body-on-a-chip” systems.  These cells can later be integrated into existing 
neuromuscular platforms, along with other related human iPSC-derived cell lines for a more 
complete investigation of human physiology, disease pathology, and drug discovery.  
  
57 
 
Results  
 
Morphological analysis and quantification of bag fibers 
 
Myoblasts derived from iPSCs were differentiated on DETA modified and collagen coated glass 
coverslips using an extrafusal-centered muscle differentiation protocol and an intrafusal-centered 
protocol (130) (Figure 17). Cells were fixed and evaluated at 15-20 days in vitro for bag fiber 
specific morphology by phase contrast imaging. Some myofibers from the extrafusal 
differentiation protocol showed some intrafusal-like morphology, including myotubes with 
collections of nuclei consistent with both bag and chain fiber morphologies (Figure 18 B and E). 
However, the majority of intrafusal-like fiber morphologies in these cultures were largely 
atypical in size and structure and very few bag fibers could be distinguished. Numerous 
myofibers from the intrafusal differentiation protocol using the iPSC-derived myoblasts 
indicated typical bag and chain intrafusal fiber morphologies (Figure 18 C and F) which matched 
the positive controls of intrafusal fibers derived from human satellite cells used in previous 
experiments (15, 16) (Figure 18 A and D). There was a significant increase in morphologically 
identifiable bag fibers in the iPSC-derived myoblasts treated with the intrafusal-specific protocol 
(Figure 18 G) (p = 0.002). This evidence suggests that activation of the NRG signaling pathway 
can induce intrafusal fiber differentiation from iPSC-derived myoblasts as also seen with human 
and rat satellite cells. It also indicates that the iPSC-derived myoblasts can generate both 
intrafusal and intrafusal fibers upon proper induction. Further analysis was performed to confirm 
the identity of the intrafusal fibers in the culture conditions.  
  
58 
 
 
Table 4: Medium formulations used to differentiate intrafusal fibers from induced pluripotent 
stem cells 
Reagent Final Concentration/Amount Source Catalog Number 
Differentiation Medium 1 
DMEM 
High 
Glucose, 
Pyruvate 
N/A Invitrogen 11995-065 
EGF 
recombinant 
human 
protein 
(hEGF)  
10 ng/ml Invitrogen PHG0314 
Insulin 10 µg/ml Sigma Aldrich I9278 
Bovine 
Serum 
Albumin 
(BSA) 
500 µg/ml Sigma Aldrich A9418 
Neuregulin 100 µg/ml R&D Systems 396-HB-050 
Agrin 100 ng/ml R&D Systems 550-AG 
Laminin  1 µg/ml ThermoFisher 23017015 
Differentiation Medium 2 
Neurobasal N/A ThermoFisher 21103-049 
B27 1X ThermoFisher 17504001 
Glutamax 1X ThermoFisher 35050-061 
NaCl (4M) ~31.2 mM  for 270-280 mOsm Sigma Aldrich S3014-1KG 
GDNF 10 ng/ml Cell Sciences CRG400E 
BDNF 20 ng/ml Cell Sciences CRB600D 
CNTF 5 ng/ml Cell Sciences CRC400B 
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NT3 20 ng/ml Cell Sciences CRN500D 
Reagent Final Concentration/Amount Source Catalog Number 
NT4 20 ng/ml Cell Sciences CRN501C 
Vitronectin 100 ng/ml Sigma Aldrich V8379-50ug 
IGF-1 10 ng/ml Sigma Aldrich I3769-100ug 
cAMP 1µM Sigma Aldrich A9501-1G 
Shh 50 ng/ml R&D Systems 1845-SH-100 
RA 0.1 µM Sigma Aldrich R2625 
Agrin 100 ng/ml R&D Systems 550-AG 
Laminin 1 µg/ml ThermoFisher 23017015 
NGF 100 ng/ml R&D Systems 256-GF-100 
NRG 100 ng/ml R&D Systems 396-HB-050 
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Table 5: Medium formulations used to differentiate extrafusal fibers from induced pluripotent 
stem cell derived myoblasts 
Reagent Final Concentration/Amount Source Catalog 
Number 
DK-HI Medium 
DMEM/F12 (1:1) N/A Gibco 21041-025 
Knockout Serum 
Replacement (KSR) 
150ul/ml ThermoFisher 10828028 
HGF 10 ng/ml PeproTech 315-23-
20UG 
IGF 2 ng/ml Sigma 
Aldrich 
I1271-MG 
β-mercaptoethanol 99mM Gibco 21985-023 
MEM Non-essential 
Amino Acids 
1X Gibco 11140-050 
N2 Medium 
DMEM/F12 (1:1) N/A Gibco 21041-025 
Insulin-Transferrin-
Fetuin 
1X Gibco 41400-45 
L-Glutamine 1X Gibco 25030-081 
N2 supplement 1X Gibco 17502-048 
  
61 
 
 
Figure 17: Cell culture protocol. Cells were differentiated into myoblasts from a previous 
protocol and frozen into stocks. Cells were then expanded and treated with either intrafusal fiber 
differentiation or extrafusal fiber differentiation. 
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Figure 18: Phase Contrast Analysis. Morphological comparison between Intrafusal fibers 
derived from satellite cells and iPSC myoblasts treated with different differentiation protocols. 
A) and D) Cultures of satellite cells treated with an intrafusal induction protocol. B) and E) 
Cultures of iPSC myoblasts treated with an extrafusal-centered differentiation protocol C) and F) 
Cultures of iPSC myoblasts treated with an intrafusal induction protocol. White arrowheads 
show cells with intrafusal morphology. G) Quantification of morphologically assessed bag 
fibers. (Error bars=SEM, p=0.002). All scale bars are 100 microns. 
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Immunocytochemical analysis 
 
To investigate the role of NRG and other differentiation factors on the induction of intrafusal 
fibers in iPSCs, we evaluated the phosphorylation of ErbB2 in cultures treated with and without 
an intrafusal differentiation specific protocol. Immunocytochemistry was performed to evaluate 
the level of phosphorylation of ErbB2 receptors to determine the phenotype of the muscle fibers. 
IPSC-derived myoblasts were differentiated on DETA modified and collagen coated glass 
coverslips using an extrafusal-centered muscle differentiation protocol and an intrafusal-centered 
protocol. Cells were fixed at 15-20 days in vitro and evaluated for pErbB2 staining. Myofibers 
found in both satellite-derived cultures and iPSC-derived cultures treated with the intrafusal 
differentiation protocol exhibited typical pErbB2 staining. Numerous clusters of receptors 
throughout the membrane were observed (Figure 19 A-E and 19 K-O). However, the iPSC-
derived myoblasts treated with extrafusal differentiation had significantly fewer clusters of 
pErbB2 (Figure 19 F-J, P) (p=0.00054). This contrast indicates specific enhancement of the NRG 
signaling pathway in these myofibers under intrafusal induction conditions. To further confirm 
the increased induction of intrafusal fibers through NRG activation, cells were evaluated by S46 
staining. S46 is a slow myosin heavy chain specific for intrafusal fibers (131). IPSC-derived 
myoblast cultures treated with the extrafusal-specific protocol had significantly fewer s46 
positive cells than the iPSC-derived myoblast cultures treated with the intrafusal differentiation 
protocol (Figure 20 K) (p=0.03). These data indicate a lack of natural development of intrafusal 
fibers using an extrafusal differentiation protocol and an increase in the amount of intrafusal 
fibers using the intrafusal protocol due to an increased activation of the ErbB2 receptor mediated 
pathway in response to NRG and other intrafusal differentiation factors. 
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Figure 19: Immunocytochemical Analysis of the myotubes induced under different conditions. 
Molecular comparison between ErbB2 phosphorylation in Intrafusal fibers derived from satellite 
cells and iPS cells treated with different differentiation protocols. A-E) Cultures of satellite cells 
treated with an intrafusal induction protocol. F-J) Cultures of iPS cells treated with an extrafusal-
centered differentiation protocol K-O) Cultures of iPS cells treated with an intrafusal induction 
protocol. P) Quantification of pERBb2 clustering within iPSC cultures. (Error bars are SEM, 
***p=0.00054). All scale bars are 100 microns. 
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Figure 20: Immunocytochemical Analysis of the myotubes induced under different conditions. 
Molecular comparison between s46 expression in Intrafusal fibers derived from iPS cells treated 
with different differentiation protocols. (Error bars are SEM, *p=0.03) All scale bars are 100 
microns. 
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Discussion 
 
This work demonstrates the induction of intrafusal fibers from iPSCs that now enables a range of 
investigations into various disease models of the spinal stretch reflex arc. Previous work has 
demonstrated the differentiation of human muscle from iPSCs, however, this is the first study 
targeting the differentiation of intrafusal fibers from iPSCs demonstrating successful 
differentiation supported by morphological and immunocytochemical evidence. These cells can 
now be integrated into existing “body-on-a-chip” testing platforms for a more thorough 
evaluation of the neuromuscular reflex arc, neuromuscular diseases, and for predicting drug 
efficacy and safety in clinical trials. For example, numerous compounds are known to mediate 
specific effects on the muscle spindle, including its activity (132) development, (133) and the 
ability to propagate pain to the central nervous system (134). Having a platform for functional 
evaluation of these activities in an in vitro setting will allow for more through preclinical 
evaluations in an attempt to reduce clinical trial failures.   
Recent evaluations of the neuromuscular reflex arc have used “body-on-a-chip” testing platforms 
to elucidate functionally relevant data for predictions of human physiology and drug efficacy, 
safety, and toxicity. These systems have investigated the efferent neuromuscular processes of 
exercise (135) and contraction (13) as well as afferent innervation of intrafusal fibers by sensory 
neurons (14, 15). To enable these in vitro investigations to be more clinically relevant, iPSCs 
show great promise due to their ability to model specific patient physiology, especially for 
disease phenotypes. As shown in previous publications, iPSCs can be differentiated into 
extrafusal fibers, (130) motoneurons, (128) and sensory neurons (129) but the differentiation of 
intrafusal fibers from human iPSCs has not been reported. This work demonstrates the 
differentiation of iPSC-derived intrafusal fibers, further advancing “body-on-a-chip” technology 
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to deliver disease-specific, or even patient-specific, results without sacrificing inappropriate 
animal models.  
In previous work, NRG has been used to induce the differentiation of intrafusal fibers from both 
rat (34) and human cell lines (15). While these cells can be used to determine certain basic 
aspects of physiology, the use of disease specific iPSCs is becoming more experimentally 
significant for the progression of drug and disease studies into clinical trials. This work outlines 
the induction of intrafusal fibers from iPSCs using the administration of NRG and other 
intrafusal fiber inducing factors. Upon treatment with an intrafusal-specific protocol the average 
quantity of iPSC-derived bag fibers per field of view increased from 0.76 ± 0.17 to 1.8 ± 0.27 
(mean ± SEM) (Figure 18). Additionally, the morphologies present in the iPSC-derived 
intrafusal fiber cultures more closely resembled those in previous publications (14-16, 34, 44) 
(Figure 18). This data suggests NRG-mediated differentiation has occurred in the iPSC-derived 
myoblast cultures. Immunocytochemistry for pERbB2 and S46 was used to further confirm the 
activation of the NRG signaling pathway and the increased induction of intrafusal fibers.  Each 
of these markers have been previously used as an indicator for intrafusal fiber identity (16, 131). 
An increase in the average level of phosphorylation of the ErbB2 receptors of individual 
myotubes from 26.2 ± 2.84 to 67.5 ± 7.81 (mean ± SEM) (Figure 19) and an increase in the 
number of myotubes positive for S46 staining from 0.73 ± 0.21 to 2.28 ± 0.26 (mean ± SEM) 
(Figure 20), confirms increased differentiation of intrafusal fibers in a human iPSC-derived 
culture using this protocol. A similar increase in both immunocytochemical markers 
demonstrates that the intrafusal-specific differentiation protocol induced increased differentiation 
of the iPSC-derived myotubes. A slightly lower increase derived from phase quantification could 
be due to the fact that only bag fibers were counted for the intrafusal quantification under phase 
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contrast microscopy. It should be noted that the amount of intrafusal fibers present within muscle 
tissue is highly variable and the reasons for which have yet to be fully understood(136-138). 
Further evaluation of this differentiation system will drive current understanding toward a more 
efficient differentiation process.  
This work is the first evidence indicating that NRG can be used to drive human iPSC- derived 
myoblasts toward the intrafusal fiber lineage. The incorporation of iPSC-derived intrafusal fibers 
into existing neuromuscular testing platforms will allow for a more clinically relevant method for 
disease pathology analysis and drug discovery testing. By incorporating iPSCs derived from 
genetic mutant variants, it is now possible to identify the specific roles of these mutations on 
muscle spindles; a first for neuromuscular diseases such as ALS and SMA where the 
involvement of mechanosensation in disease progression is known but not yet fully elucidated 
(139, 140). 
Materials and Methods 
 
Surface modification 
 
Glass coverslips (18mm round, VWR, 48380-046) were cleaned and functionalized by a Harrick plasma 
cleaner (model PDC-32G) by expose to an oxygen plasma from high purity oxygen gas. The coverslips 
were submerged in a reaction solution of 1% v/v trimethoxysilyspropyldiethylenetriamine (DETA, United 
Chemical Laboratories, Inc., T2910-KG) in dry toluene (VWR, BDH1151-4LG) and heated for 30 
minutes to just below the boiling point of toluene (110.6°C). The vessel was then removed from heat and 
allowed to cool at room temperature for 30 minutes. Next the coverslips were rinsed in 3 serial toluene 
baths and submerged in dry toluene and heated for 30 minutes to just under the boiling point of toluene. 
The surfaces were then removed and cured overnight (~15hrs) in an oven at approximately 110°C. 
Surfaces were characterized by goniometry and X-ray photoelectron spectroscopy (XPS) to verify the 
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DETA functionalization according to Das et. al. 2006 (7). Goniometry characterization was performed by 
contact angle goniometry with a 5 µl droplet of water. XPS characterization was performed with a 
Thermo Scientific ESCALAB 220i-XL instrument with aluminum Kα X-rays and a 90° take off 
angle.  
Satellite cell culture 
 
Satellite cells were cultured according to previously published techniques (68) (Figure 17, Table 
4). Briefly, cells were plated at ~200 cells per mm2 and expanded in Lonza human skeletal 
growth medium (Lonza, CC3160 or CC-3246 plus 10mM L-glutamine and CC-4139) 
supplemented with 15% FBS on 18mm round coverslips that were DETA modified then 
Collagen (ThermoFisher, A1048301, 60 ug/ml) coated until the cells reached ~80-90% 
confluency. Cells were then given a full medium change into differentiation medium 1 and given 
a half change of differentiation medium 1 two days after differentiation was initiated. After four 
days of differentiation, cells were given a full medium change of differentiation medium 2 and 
then a half change of differentiation medium 2 two days after the culture was switched to 
differentiation medium 2. After four days in differentiation medium 2, cells were fed with a half 
change of NBActiv4 (Brainbits, NB4-500) medium supplemented with 1X antibiotic/antimycotic 
(ThermoFisher, 15240062) every other day until the culture was ready for analysis (10-15 days 
after differentiation).  
iPSC extrafusal cell culture 
 
IPSCs were obtained from Coriell Institute for Medical Research (Camden, New Jersey). Cells 
were cultured according to previously published techniques (130) until the myoblast stage and 
then frozen as stocks in liquid nitrogen with 10% DMSO (Figure 17). Cells were then expanded 
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and differentiated as previously published.(130) Briefly, cells were plated at ~200 cells per mm2 
and expanded in Myocult medium (Stemcell Technologies, 36253 and 5982) on 18mm 
coverslips that were DETA modified then Collagen (ThermoFisher, A1048301, 60 ug/ml) coated 
until cells reached ~80-90% confluency. Cells were then given a half medium change with DK-
HI supplemented with dexamethasone. Two days after feeding with DK-HI, cultures were given 
a half medium change of N2 medium (Table 5). Cultures were fed every other day until the 
culture was ready for analysis (10-15 days after differentiation).  
 
iPSC intrafusal cell culture 
 
IPSCs were obtained from Coriell Institute for Medical Research (Camden, New Jersey). Cells 
were cultured according to previously published techniques (130) until the myoblast stage and 
then frozen as stocks in liquid nitrogen with 10% DMSO. Myoblasts were then expanded as 
previously published (130) and differentiated using a modified protocol. Myoblasts were 
cultured according to previously published techniques (15). Briefly, myoblasts were plated at 
~200 cells per mm2 and expanded in Myocult medium (Stemcell Technologies, 36253 and 5982) 
on 18mm round coverslips that were DETA modified then Collagen (ThermoFisher, A1048301, 
60 ug/ml) coated until cells reached ~80-90% confluency. Cells were then given a full medium 
change into differentiation medium 1 and then a half change of differentiation medium 1 two 
days after differentiation was initiated. After four days of differentiation, cells were given a full 
medium change of differentiation medium 2 and then a half change of differentiation medium 2 
two days after the culture was switched to differentiation medium 2. After four days in 
differentiation medium 2, cells were fed with a half change of NBActiv4 (Brainbits, NB4-500) 
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medium supplemented with 1X antibiotic/antimycotic (ThermoFisher, 15240062) every other 
day until the cultures were ready for analysis (10-15 days after differentiation).  
 
Immunocytochemistry-pErbB2 and phalloidin 
 
Cells were fixed with 4% paraformaldehyde for 15 minutes and then rinsed 2 times with 
phosphate buffered saline (PBS) and stored in a third wash of PBS until immunocytochemical 
treatment (~0-14 days). Before immunocytochemistry, cells were treated with a blocking 
solution (donkey serum and 10% BSA in PBS) for 2 hours then treated with rabbit-anti-pErbB2 
488 antibody (EMD Millipore, 16-235, 1:250 dilution) and Phalloidin 568 (Fisher Scientific, 
A12380, 1:40 dilution) for 2 hours. Cells were rinsed with PBS for 5 minutes, then rinsed with 
PBS and DAPI for 10 minutes and then rinsed with PBS for 15 minutes. Glass coverslips were 
mounted onto glass slides using ProLongTM gold antifade mounting medium (ThermoFisher, 
P36931). Slides were imagined using a Zeiss Axioskop 2 Mot plus spinning disk confocal 
microscope.  
 
Immunocytochemistry-S46 and phalloidin 
 
Cells were fixed with 4% paraformaldehyde for 15 minutes and then rinsed 2 times with 
phosphate buffered saline (PBS) and stored in a third wash of PBS until immunocytochemical 
treatment (~0-14 days). Before immunocytochemistry, cells were permeabilized with 0.1% 
Triton X-100 for 15 minutes and treated with a blocking solution (donkey serum and 10% BSA 
in PBS) for 2 hours. Cells were then treated with Mouse-anti-S46 antibody (Developmental 
Studies Hybridoma Bank, S46-s) overnight. The next day, cells were rinsed for 5, 10, and 15 
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minutes with PBS and treated with donkey-anti-mouse 488 Alexa Fluor® antibody 
(ThermoFisher, A21202, 1:250 dilution) and Phalloidin 568 (1:40 dilution) for 2 hours. Cells 
were then rinsed with PBS for 5 minutes, rinsed with PBS and DAPI for 10 minutes and rinsed 
with PBS for 15 minutes. Glass coverslips were then mounted onto glass slides using 
ProLongTM gold antifade mounting medium (ThermoFisher, P36931). Slides were imagined 
using a Zeiss Axioskop 2 Mot plus spinning disk confocal microscope.   
Image analysis  
 
Quantification of intrafusal morphology was performed across three separate cultures for the two 
iPSC-derived myoblast differentiation protocols. Within each culture, five random phase contrast 
images were taken from each of the two replicate coverslips for each protocol, for a total of 30 
images per condition.  A nested statistical design was employed, in which the 5 replicate images 
in each coverslip were nested in the independent coverslip samples (n = 6 coverslips). Images for 
pErbB2 and S46 quantification were obtained similarly to those for the intrafusal morphology, 
with n = 6 coverslips across 3 cultures and n = 8 coverslips across 4 cultures, respectively, each 
with 5 replicate images. For each quantification, two tailed t-tests (α = 0.05, n = 6 or 8 
coverslips) were performed to compare the numbers of intrafusal fibers per field of view, 
numbers of pErbB2 clusters per myotube, and numbers of S46 positive myotubes per field of 
view between the two differentiation protocols. Error bars in each figure are presented as 
standard error of the mean (SEM).  
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CHAPTER FIVE: INVESTIGATION OF NOCICIEPTIVE MUSCLE 
SPINDLE ACTIVITY 
 
Introduction 
 
The muscle spindle has largely been studied for its involvement in neuromuscular 
communication efficiency and proprioception. However, increasing evidence suggests its 
involvement in neuropathic pain, a term used to describe nerve damage resulting in the 
perception of pain (141). This damage can result in sensitization of the nerve endings and 
allodynia, or a painful response to a typically non painful stimulus (141). Many links exist 
between neuropathic pain and afferent skeletal muscle activity (96, 142-147), some suggesting 
nociceptor-mediated pain originating in the muscle spindle (17). The exact mechanisms involved 
are of great research interest for as their investigation could lead to therapeutic innovations for 
pain. Thus far, multiple afferent cells, including, intrafusal fibers (96, 143), nociceptors (144), 
and other sensory neurons (143) have been linked to the propagation of pain signals from the 
muscle tissue. To have a complete in vitro model of the human neuromuscular reflex arc, it is 
important to have these functionalities represented in an in vitro platform.  
Nociceptors are sensory neurons specialized for the perception of noxious stimuli (141). They 
are present in a wide variety of tissues including skin, muscles, joints and fascia (148). Recent 
research has allowed for the characterization of many nociceptive agonists including heat, 
changes in pH, and specific molecules. Of particular interest to this work, capsaicin, a well 
characterized nociceptive agonist is the molecule found in spicy peppers that gives them their 
“hot” flavor (149). This molecule binds to transient potential receptor vanilloid-1 (TRPV1) 
found on nociceptors(150). This binding opens the nonspecific TRPV1 receptor which allows for 
a dramatic influx of calcium and sodium ions, evoking the perception of pain. However, if the 
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TRPV1 ion channel is exposed to capsaicin for a long enough time period, the associated neuron 
gets flooded with calcium and can no send action potentials, leading to a sensation of numbness 
(149). This mechanism is widely utilized in clinical settings as a method of delivering pain relief 
with the topical application of capsaicin (151). In an in vitro setting, this mechanism can be used 
to confirm likely nociceptive capabilities of the cell type in question. This work demonstrates the 
use of capsaicin on human neural progenitor-derived sensory neurons to evaluate nociceptive 
capability. Integration of these nociceptors into the existing platform for neuromuscular reflex 
arc will incorporate a perspective on pain when evaluating neuromuscular activity in regard to 
normal, diseased, and drug treatment conditions. 
As described in Chapter 1, intrafusal fibers are the sensory component of skeletal muscle tissue. 
These fibers form a collection called a muscle spindle which is innervated by both afferent and 
efferent neurons. This spindle is embedded within skeletal muscle tissue and mediates afferent 
muscular perception (44). However, recent research suggests its potential role in the propagation 
of pain perception, including injury and inflammation, particularly in regard to the presence of 
the TRPV1 ion channel (142, 145, 147, 152-155). This work investigates the potential for 
intrafusal fibers of initiating the propagation of noxious stimuli to the CNS. 
The confirmation of nociceptive activity in vitro is difficult to define. There is no method of 
interrogating neurons for “pain” or how much of the sensation would be perceived by the CNS. 
Therefore, it is important to carefully investigate and utilize a functional analog to demonstrate 
the involvement of pain within an in vitro testing platform for the neuromuscular reflex arc. 
First, nociceptive capability must be demonstrated in the cells themselves. Later, they can be 
fully integrated into the existing neuromuscular testing platform. Here we demonstrate 
nociceptive activity in neurons derived from commercially available human neural progenitor 
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(hnp1) cells and the possible nociceptive involvement of human intrafusal fibers. This is a first 
step toward integrating more complex pain-linked disease states to the neuromuscular reflex arc 
testing platform. 
Results 
 
Immunocytochemical analysis of hNP1-derived sensory neurons 
 
To confirm the presence of nociceptive cells in hNP1-derived sensory neurons, we evaluated the 
presence of nociceptive membrane channels on the membranes of the mature cells with 
immunocytochemistry. HNP1 cells were expanded and differentiated using an adapted protocol 
from previous methods (15). The differentiation protocol yields a mixed population of sensory 
neurons, therefore further analysis was required to confirm nociceptive identity. Once the cells 
reached maturity, they were fixed and evaluated by immunocytochemistry for the presence of 
TRPV1, the receptor for capsaicin, and the high-affinity receptor tyrosine kinase A (TRKA) both 
of which are found selectively on nociceptors(156). A correlation between TRPV1 and TRKA 
expression was observed (Figure 21), suggesting that the cells positive for both markers are 
indeed nociceptors. Functional analysis of the TRPV1 channel will further confirm their 
nociceptive identity. 
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Figure 21: Immunocytochemical analysis of hNP1-derived neurons. Evaluation of TRPV1 and 
TRKA expression in hNP1-derived neurons. All scale bars are 100 microns. 
 
Functional evaluation of hNP1-derived neurons 
 
To determine the nociceptive functionality of these cells, they were treated with capsaicin, a 
known nociceptive agonist for the TRPV1 channel. HNP1 cells were expanded and differentiated 
as with the immunocytochemical evaluation. Upon maturity, cells were replated onto custom 
microelectrode arrays (cMEAs), allowed to recover for 3-5 days and evaluated using a 
customized amplifier unit along with customized detection software. Upon application of 2 µM 
capsaicin, a likely response was observed (Figure 22). This demonstrates a coordination with 
neuronal firing and the administration of this nociceptive agonist, suggesting in vitro nociceptive 
functional activity and further confirming the nociceptive population within the hNP1-derived 
sensory neurons. 
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Figure 22: Raster plot demonstrating the electrophysiological response of hNP1-derived neurons 
to capsaicin 
Immunocytochemical evaluation of intrafusal fibers 
 
To determine the potential involvement of intrafusal fibers in pain, these cells must be evaluated 
for known mediators of nociception. Human skeletal muscle myoblasts were expanded and 
differentiated according to previous methods. Upon maturation, cells were fixed and evaluated 
by immunocytochemistry for the presence of TRPV1. The intrafusal cultures demonstrated a co-
staining of TRPV1 and S46, a known indicator of intrafusal fiber identity (131) (Figure 23). The 
presence of a well-known nociceptive mediator both in the nuclei and on the cellular membrane 
suggests a possible role of human muscle spindles in nociception.  
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Figure 23: Immunocytochemical analysis of human skeletal muscle. Cultures were evaluated for 
TRPV1 and S46. All scale bars are 100 microns. 
 
Discussion 
 
This work demonstrates the potential for interrogation of pain on an in vitro neuromuscular 
reflex arc testing platform. Evidence of immunocytochemical markers and the functional 
evaluation of nociceptive activity within hNP1-derived sensory neurons suggests the 
incorporation of these cells into an existing neuromuscular evaluation platform will allow for an 
opportunity to evaluate pain in vitro. Additionally, the presence of TRPV1 on in multiple locales 
(membrane and nuclei) of intrafusal fibers suggests a role of this cell type in nociception. Both 
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cell types can easily be integrated into existing neuromuscular testing platforms for a potential 
new way to evaluate pain in vitro.  
Materials and Methods 
 
Surface preparation 
 
Glass coverslips (18mm round, VWR, 48380-046) were cleaned and functionalized by a Harrick 
plasma cleaner (model PDC-32G) by exposure to an oxygen plasma from high purity oxygen 
gas. Coverslips and cMEAs were submerged in a reaction solution of 1% v/v 
trimethoxysilyspropyldiethylenetriamine (DETA, United Chemical Laboratories, Inc., T2910-
KG) in dry toluene (VWR, BDH1151-4LG) and heated for 30 minutes on a hot plate to just 
below the boiling point of toluene (110.6°C). The vessel was then removed from heat and 
allowed to cool at room temperature for 30 minutes. Next the surfaces were rinsed in 3 serial 
toluene baths and submerged in dry toluene and heated for 30 minutes on a hot plate to just under 
the boiling point of toluene. The surfaces were then removed and cured overnight (~15hrs) in an 
oven at approximately 110°C. Surfaces were characterized by goniometry and X-ray 
photoelectron spectroscopy (XPS) to verify the DETA functionalization according to Das et. al. 
2006 (7). Goniometry characterization was performed by contact angle goniometry with a 5 µl 
droplet of water. XPS characterization was performed with a Thermo Scientific ESCALAB 220i-
XL instrument with aluminum Kα X-rays and a 90° take off angle. Surfaces were then sterilized 
with 70% Ethanol and allowed to dry under sterile laminar flow. The cMEAs were then 
assembled into custom polymethylmethacrylate and polydimethylsiloxane housing systems. The 
surfaces were next coated with poly-ornathine (15 µg/ml, Sigma, P3655) overnight. The next 
day, the surfaces were rinsed twice with PBS and coated with laminin (1 µg/ml Invitrogen 
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23017-015) and fibronectin (10 µg/ml EMD Millipore FC010) overnight. The next morning the 
surfaces were rinsed twice with PBS and were ready for cell seeding.   
Human neural progenitor cell expansion and differentiation 
 
Human neural progenitor (STEMEZ TM hNP1, ) were obtained from Neuromics (Edina, 
Minnesota) and expanded in RenCell medium (EMD Millipore, SCM005) supplemented with 
basic fibroblast growth factor (20ng/ml, R&D, 233-FB) and epidermal growth factor (20ng/ml, 
R&D, 236-EG) on Matrigel coated polystyrene (Corning Life Sciences, 354230). Matrigel was 
incubated on polystyrene at a 1:100 dilution in DMEM : F12 (Gibco, 21041-025) for one hour at 
room temperature. Cells were given a fill medium change every other day until ~90% confluence 
was reached. Cells were then replated onto poly-ornathine/ fibronectin/ laminin, coated 
coverslips with 0.05% trypsin and 0.2% trypsin inhibitor. Cells were fed every other day with 
RenCell medium until ~90% confluency was reached. Differentiation was then initiated with a 
full change of 100% KSR medium (knockout DMEM, ThermoFisher, 10829018; knockout 
serum replacement, 150 µl/ml, ThermoFisher, 10828028; 2 mM L-glutamine, Gibco, 25030-081; 
antibiotic/antimycotic, 1X, ThermoFisher, 15240-062; MEM Non-essential amino acids, 1X, 
Gibco 11140-050; 55 µM β-mercaptoethanol, Gibco, 21985-023)  supplemented with 100 nM 
LDN (Tocris, 6053/10) and 10 µM SB431542 (Tocris, 1614/1) at day 1 of differentiation. On 
day 3, cells were given a full medium change of 100% KSR medium supplemented with 100 nM 
LDN, 10 µM SB431542, 3 µM CHIR99021 (Tocris, 4423/10), 10 µM SU5402 (Tocris, 3300), 
and 10 µM DAPT (2643/10). On day 5, cells were given a full change of 75% KSR medium and 
25% N2B Medium (DMEM/F-12, phenol red free, ThermoFisher, 21041-025; 200 µg/ml Human 
Apo-transferrin, R&D, 3188-AT; 25 µg/ml Insulin, Millipore, 407709; 1.56 mg/ml D-(+)-
glucose, anhydrous, Sigma, G-7012) supplemented with 100 nM LDN, 10 µM SB431542, 3 µM 
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CHIR99021 , 10 µM SU5402 , and 10 µM DAPT. On day 7, cells were given a full change of 
50% KSR medium and 50% N2B Medium supplemented with 100 nM LDN, 10 µM SB431542, 
3 µM CHIR99021 , 10 µM SU5402 , and 10 µM DAPT. On day 9, cells were given a full change 
of 25% KSR medium and 75% N2B Medium Supplemented with 100 nM LDN, 10 µM 
SB431542, 3 µM CHIR99021 , 10 µM SU5402 , and 10 µM DAPT. On day 1, cells were given a 
full change of 100% N2B Medium Supplemented with 100 nM LDN, 10 µM SB431542, 3 µM 
CHIR99021 , 10 µM SU5402 , and 10 µM DAPT. .On day 13, cells were given a full medium 
change with N2B medium supplemented with 25 ng/ml human-b-NGF (R&D, 256-GF), 25 
ng/ml BDNF (Cell Sciences, CRB600B), and 25 ng/ml GDNF(CRG400B). On day 15, cells 
undergoing electrophysiological analysis were replated onto Poly-ornathine/laminin/fibronectin 
coated cMEAsCells were fed every 3-4 days in this final medium until cells were ready for 
analysis ( ~5-15 days). 
Electrophysiological Evaluation of hNP1 cells 
 
Once hNP1 cells reached maturity (10-15 days post differentiation) cells were replated onto 
custom cMEAs within housings and recovered for 3-5 days. The housings were then attached to 
a custom amplifier circuit to observe and record electrical signals detected from the neurons. 
First, 10 µl warmed medium was added as a negative control then capsaicin (1-2 µM ,Fisher 
Scientific, ICN202757) was added at recorded time points and electrophysiological response was 
recorded on a custom software program.   
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Human Intrafusal fiber differentiation 
 
Human skeletal muscle was obtained from Lonza (CC-2580) and expanded in Lonza human 
skeletal growth medium (CC-3160) supplemented with 15% FBS until ~70-80% confluence was 
reached. Then the medium was fully switched to differentiation 1 medium (DMEM 
(Invitrogen 11775-040), Insulin (Sigma I9278) at 10 µg/ml, BSA (Sigma A9418) at 
500 µg/ml, and EGF (Invitrogen 13247-051) at 10 ng/ml)(36) and fed every 2 days for 4 days. 
At this point, the medium was switched to differentiation 2 medium (described in detail in 
Guo et al.(15)) and MNs were added to co-cultures at 50 cells per mm2. The cells were fed 
every two days with differentiation 2 medium and maintained for four days. After this point, 
the medium was given a half change with NBActive4 differentiation medium. The cells were 
maintained in this medium for the remainder of the culture and fed every two days until 15–30 
DIV total when they were analyzed via immunocytochemical analysis.  
Immunocytochemical analysis 
 
Upon maturation, cells were fixed with 4% paraformaldehyde for 15 minutes then rinsed three 
times with PBS. At this point, cells were either stored in PBS for 0-14 days or incubated with 
permeabilization solution for 15 minutes (Triton X-100) and then blocking solution (5% Donkey 
serum +0.5% BSA in PBS) for 2 hours to prevent nonspecific binding. Cells were then 
incubated with primary antibodies overnight (Rabbit anti TRKA,1:100 Abcam, ab8871 or 
Guinea Pig-anti-TRPV1, 1:100, Invitrogen PA1-29770). The next day cells were rinsed three 
times with PBS and incubated with secondary antibodies (Goat-anti-Guinea Pig-488 Alexa 
Fluor, ThermoFisher A-11073 or Donkey-anti-Rabbi 568 AlexaFluor, ThermoFisher, A10042) in 
a 1:250 dilution for 1-2 hours. Cells were then rinsed for 5minutes in PBS, 10 minutes in PBS 
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with DAPI (1:1000, ThermoFisher D1306), and 15 minutes with PBS then mounted onto glass 
coverslips using ProLongTM gold antifade mounting medium. Slides were imagined using a Zeiss 
Axioskop 2 Mot plus spinning disk confocal microscope.  
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CHAPTER SIX: PIEZOELECTRIC BIOMEMS CANTILEVER FOR 
MEASUREMENT OF MUSCLE CONTRACTION AND FOR ACTUATION 
OF MECHANOSENSITIVE CELLS 
 
The work in this chapter was submitted for publication as follows. This work will also be 
included in the doctoral dissertation of Elizabeth Coln. 
 
Coln, E., Colón, A., Long, C., Narasimhan Sriram, N., Esch, M., Prot, J.M., Elbrecht, D., Wang, 
Y., Jackson, M., Shuler, M., Hickman, J.J. Piezoelectric BioMEMS cantilever for measurement 
of muscle contraction and for actuation of mechanosensitive cells. MRS Communications. June 
11, 2019. 
JJH, MLS, CJL conceived and designed the experiments; CJL, ME, JMP, and YW fabricated the 
device; AC and DHE performed the experiments; EAC, AC, CJL, NNS, MJ analyzed the data; 
EAC, AC, DHE, CJL, and JJH prepared the manuscript. 
 
Introduction 
 
Microcantilever sensors have been increasingly used in biomedical microelectromechanical 
systems (bioMEMS) devices to measure small scale mechanical movement and are typically 
silicon-based cantilevers due to availability and easy integration with silicon-based 
technology.(157) One application of these microcantilever sensors is in the determination of 
contractile force of cardiac and skeletal muscle tissues using in vitro “body-on-a-chip 
systems”.(10, 158-162) These “body-on-a-chip” systems integrate biology and engineering to 
measure the biochemical, mechanical, and physiological responses of organ analogues to predict 
human response to drug and chemical exposure.(158, 159, 163, 164) The existing 
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microcantilever sensors in “body-on-a-chip” systems utilize imaging methods or optical laser 
deflection of cantilevers for calculating contractility(157, 159) and rely on imaging methods or 
expensive optical detection components.(165, 166) Since piezoelectric materials have high 
sensitivity and the ability to convert mechanical energy to an electrical signal, they have been 
used in a variety of microscale sensor systems such as pressure sensors and chemical 
sensors,(167-169) and as biosensors to detect biological targets, such as microbes, proteins, 
viruses, and nucleic acids.(170) Additionally, the ability of piezoelectric materials to convert 
electrical signals to mechanical energy has led to their use as microactuators.(171) However, 
these biosensor methods are based on shifts in the resonance frequencies to measure changes in 
mass on the surface and are not suited for measuring dynamic force changes. Extending the use 
of piezoelectric materials to cantilever-based muscle contraction bioMEMS devices would 
enable a direct electrical readout of muscle contraction. Moreover, these cantilevers could also 
be used in reverse as actuators to impose a stress on tissues attached to the device, specifically 
the sensory portion of the reflex arc. The stretch reflex arc refers to how the central nervous 
system senses and responds to peripheral stimuli to regulate skeletal movement and is composed 
of skeletal muscle, the muscle spindle, motoneurons, and sensory neurons. The sensory portion is 
composed of intrafusal fibers embedded in the muscle tissue of the muscle spindle and 
proprioceptive sensory neurons.(172-174) Development of an in vitro sensory circuit of the 
reflex arc would improve the overall understanding of the mechanosensitive feedback, allowing 
opportunities to create more physiologically relevant systems and for investigation of 
neuromuscular diseases. 
This present study details the design and fabrication of a piezoelectric bioMEMS cantilever 
which can act as either a sensing element for muscle contraction or as an actuator to apply 
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mechanical force to cells. This device incorporates a piezoelectric element composed of a thin 
film of aluminum nitride (AlN) on top of the cantilever sandwiched between two platinum 
electrodes. As a sensor, bending of the piezoelectric cantilever caused by contracting iPSC-
derived cardiac muscle grown on the cantilever surface produced a voltage across the 
piezoelectric element, which was measured by an external amplifier.  As an actuator, a periodic 
voltage was applied to the piezoelectric cantilevers and the resultant bending was measured 
using an optical beam displacement method. This bioMEMS system has the advantage of being 
able to acquire a direct electrical signal from the cantilever with a simple system setup for high 
content systems and may offer the advantage of high-throughput data collection by integration 
with current robotic screening systems in drug discovery. 
 
Experimental Details 
 
Design and fabrication of piezoelectric cantilevers 
 
Piezoelectric cantilever devices were fabricated at the Cornell Nanoscale Science & Technology 
Facility (Ithaca, NY) using standard microfabrication processes. Each chip included 16 
individual microscale cantilevers each 100 µm wide, 750 µm long, and 4 µm thick with a total 
chip size of 17 mm x 14 mm. The 5-inch photomasks for each layer to produce the piezoelectric 
cantilevers were designed using L-edit layout editor (Tanner). For production of the devices, 
silicon oxide and silicon nitride layers were grown via Plasma Enhanced Chemical Vapor 
Deposition (PECVD) (GSI PECVD System, Novanta, Inc., Bedford, MA); metal layers (titanium 
and platinum) were deposited via electron-beam evaporation (CHA Mark 50 e-Beam Evaporator, 
CHA Industries, Fremont, CA); the aluminum nitride (AlN) was sputtered using an aluminum 
target in a nitrogen plasma environment (ATC Orion Sputter Deposition Tool, AJA International, 
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Inc., Scituate, MA); oxide and nitride layers were etched via reactive ion etching (RIE) (Oxford 
PlasmaLab 80+ RIE System, Oxford Instruments, Concord, MA); the silicon device and handle 
layers were etched via deep reactive ion etching (DRIE) (Unaxis 770 Deep Silicon Etcher, 
Plasma-Therm, St. Petersburg, FL), and photolithography was performed using a Karl Suss MA6 
Mask Aligner (Suss Microtec SE, Garching, Germany). The fabrication process, starting from a 
silicon-on-insulator wafer with a 4 µm thick <100> silicon device layer, 1-2 µm buried oxide 
layer, and 500 µm handle wafer, is shown in Figure 24, and focuses on the production, 
patterning, and electrical isolation of the sandwich structure of AlN between two platinum 
electrodes. A 1.5 µm thick silicon dioxide layer and 300 nm silicon nitride layer were deposited 
via PECVD on the back and front (device) sides of the wafer, respectively. The piezoelectric 
element consisting of an aluminum nitride layer sandwiched between two platinum electrodes 
was produced by evaporation and liftoff of the bottom metal layer (10 nm titanium and 50 nm 
platinum) (Figure 24A), followed by reactive sputtering of 300 nm of aluminum nitride (Figure 
24B) and evaporation of a second electrode identical in composition and thickness to the first. 
Both the aluminum nitride and top electrode layers were patterned via a liftoff process (Figure 
24C). An insulation layer of silicon oxide and silicon nitride was deposited on top of the device 
layer, including the piezoelectric element (Figure 24D). The insulation layer was patterned via 
RIE to expose the contact pads and allow etching to define the cantilevers (Figure 24E). DRIE 
was then used to define the cantilevers in the device layer silicon.  To release the cantilevers and 
open a window through the wafer to the cantilevers, the oxide on the backside of the wafer was 
etched using RIE to create an etch mask for the DRIE process, which was used to perform a 
through etch of the handle wafer to the cantilevers. Buffered hydrofluoric acid (HF) was used to 
remove the buried oxide layer to fully release the cantilevers (Figure 24F). Each final cantilever 
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is 100 µm wide and 750 µm long, with a piezoelectric cantilever element 80 µm wide and 730 
µm long on the top of the silicon cantilever. In the piezoelectric cantilever chip design (Figure 
25A), each cantilever has an independent contact pad for the top and bottom platinum layers, and 
these contact pads are connected to an external amplifier. A JEOL 6400 scanning electron 
microscope (JOEL USA, Inc., Peabody, MA) was used to measure cantilever dimensions (Figure 
25B).   
 
Figure 24: Fabrication of piezoelectric cantilevers. (a) Ti/Pt bottom electrodes and contact pads 
were deposited on an SOI wafer with insulation layers on the front and backside and patterned 
via liftoff. (b) Piezoelectric AlN was reactively sputtered and patterned via liftoff. (c) Top metal 
electrodes and contact pads were deposited and patterned via liftoff. (d) Top insulation layer 
(ONO) was deposited via PECVD. (e) The insulation layer was patterned by RIE. (f) The front 
and backside were etched via DRIE to define and release the cantilevers, followed by an HF dip 
to remove the buried oxide layer. 
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Figure 25: Piezoelectric cantilever chip layout (a) Piezoelectric cantilever chip design showing 
location of cantilevers, wires, and contact pads. (b) SEM image of piezoelectric cantilevers 
showing top surface of platinum and SiO2 insulation. Because the cantilever chip was not coated 
with a separate conductive layer, the piezoelectric element and platinum wires appear darker, as 
the adjacent insulation layers charge slightly under the electron beam. 
 
Surface modification of piezoelectric cantilevers 
 
Piezoelectric cantilevers were chemically modified with a diethlyenetriamine (DETA)-
containing silane using previously published methods to enhance cell adhesion and functional 
development.(159, 175-177) Following chemical modification, the chips were incubated in 
human fibronectin (50 µg/mL) in phosphate buffered saline (PBS) at 37°C for 30 minutes just 
prior to cell plating to adsorb the fibronectin to the DETA surface for cell attachment. 
 
Cell culture on the piezoelectric cantilevers and housing system assembly 
 
Commercially available, cryogenically preserved, human induced pluripotent stem cell (iPSC) 
derived cardiomyocytes (iCell Cardiomyocytes, #CMC-100-110-005, Cellular Dynamics 
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International, Madison, WI) were plated onto piezoelectric cantilevers (2200 cells/mm2) in a 
serum-free medium according to previously published methods that described culturing these 
cells on non-piezoelectric bioMEMS cantilevers.(158-160, 176) These cardiomyocytes in our 
serum-free culture system express a mature phenotype, have robust electrical and mechanical 
function, and show appropriate functional changes in response to drug compounds.(159, 160, 
178, 179) Every 2 days, one-half of the medium was replaced with fresh medium. The 
piezoelectric chips with cultured cardiomyocytes were maintained for 7 days prior to assembling 
into housings. System housings and gaskets were manufactured from 6 mm thick transparent 
poly(methylmethacrylate) (PMMA) (McMaster-Carr, Elmhurst. IL) and 0.5 mm thick 
poly(dimethylsiloxane) (Grace Bio-Labs, Bend, OR), respectively. Both housings and gaskets 
were designed in Eagle (Autodesk) software and laser cut using a Versalaser PLS 75W laser 
cutter (Universal Laser Systems, Scottsdale, AZ). The piezoelectric cantilevers were assembled 
within the PMMA top and bottom plates, with the gaskets sealing the contact pads from the 
cantilever area, which contained 500 µL of serum-free medium.  
  
Contractile force measurement with piezoelectric cantilevers 
 
A microelectrode array (MEA) amplifier (MEA 1040, Multichannel Systems, Reutlingen, 
Germany) was interfaced to the piezoelectric cantilever chip in the housing via a custom printed 
circuit board and was used to record the electrical output from the piezoelectric cantilevers. For 
contractile force experiments, piezoelectric cantilever chips cultured with cardiomyocytes were 
assembled into system housings with 500 µL serum-free medium over the piezoelectric 
cantilevers. The force of the beating cardiomyocytes bent the cantilevers, producing a 
mechanical stress in the piezoelectric aluminum nitride, in turn generating an electric potential 
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difference across the two electrodes (Figure 26C top panel). This voltage was measured by the 
amplifier and recorded in real-time using a commercially available data acquisition software 
package (MC_Rack, Multichannel Systems, Reutlingen, Germany), and the voltage data was 
analyzed with Clampfit (Axon Instruments) software (Figure 26B and C top panel). To 
demonstrate the ability of the piezoelectric cantilever sensors to detect changes in cardiomyocyte 
function, the cardiomyocytes were dosed with 3 µM epinephrine to increase the beat frequency 
during the recording (Figure 26C, bottom panel). 
 
Figure 26: Sensing of muscle contraction using piezoelectric cantilevers. (a) Confocal image of 
skeletal muscle on a piezoelectric cantilever, with myosin heavy chain shown in red and DAPI in 
blue. (b) Schematic of recording setup for cardiomyocyte force measurements using piezoelectric 
cantilevers. (c) Measurement of cardiomyocytes on piezoelectric cantilevers showing control 
(top) and after treatment with addition of 3 µm epinephrine (bottom). 
 
Immunocytochemical imaging of cardiomyocytes on piezoelectric cantilevers 
 
Piezoelectric cantilevers were prepared for immunocytochemistry using methods that previously 
described staining these cells on non-piezoelectric cantilevers and coverslips.(173, 177) Briefly, 
cells on the piezoelectric cantilevers were fixed with a 4% (vol/vol) paraformaldehyde/PBS 
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solution for 15 minutes at room temperature, then rinsed 3X with PBS. Cardiomyocytes were 
permeabilized for 15 minutes with 0.1% Triton X-100 and then blocked with 5% donkey serum 
+ 0.5% bovine serum albumin in PBS for 1-2 hours at room temperature. Cells were incubated 
overnight at 4°C with a mouse anti-myosin heavy chain primary antibody (Developmental 
Studies Hybridoma Bank, Iowa City, IA) diluted in blocking buffer. The cells were rinsed with 
PBS for 5 minutes, 0.01% Triton X-100 for 10 minutes, and PBS for 15 minutes. The cells were 
incubated with Alexa Flour 594 (Invitrogen, Carlsbad, CA) secondary antibodies (1:250 diluted 
in blocking buffer) for 1-2 hours at room temperature. The stained samples were then rinsed with 
PBS for 5 minutes, 0.01% Triton X-100 and DAPI (Thermo Fisher P36931) for 10 minutes and 
PBS for 15 minutes and imaged using a Zeiss LSM 510 confocal microscope (Figure 26 A). 
 
Detection system for actuation of piezoelectric cantilevers 
 
For actuation experiments, acellular piezoelectric cantilever chips were assembled into system 
housings with 500 µL of PBS and interfaced through a custom printed circuit board (PCB) to a 
Model 2100 Isolated Pulse Stimulator (A-M systems, Sequim, WA) (Figure 27A). A single 
cantilever was stimulated at a time by connecting the two electrode pads to the stimulator 
through the PCB. Two pulse shapes were applied to the piezoelectric cantilever: a monophasic 
square pulse (5V, 150 ms duration, and 0.6 Hz), and a biphasic square pulse (±5V, 300 ms 
duration, and 0.6 Hz). A previously described optical detection system (158-160, 177) was used 
to measure the deflection of the piezoelectric cantilever. In this system, a 635 nm laser 
(CPS635F, Thorlabs, Newton, NJ) and linear effect photodetector (PSD9, Thorlabs, Newton, NJ) 
were located under a fixed stage and were aligned such that the laser was focused onto the tip of 
the underside of the cantilever (Figure 27A). The laser was subsequently reflected onto the 
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center of the photodetector to measure the deflections of the cantilevers as a change in position 
of the reflected laser spot on the photodetector. The deflection at the tip of the cantilever was 
then determined using methods described in Pirozzi, et al. for this system.(180) 
To understand the cantilever deflection when stimulated electrically as an actuator, a 
mathematical relationship between the input pulses and the average deflection signals was 
developed (Figure 27B and C). The deflection curves for the monophasic stimuli were averaged, 
as were those for the biphasic stimuli. The induced strain in a piezoelectric material is 
approximately linearly proportional to the electric field across the piezoelectric element, as 
shown in Equation (1), where ε is the strain in the piezoelectric material, d is the piezoelectric 
coefficient, and E is the electric field for the inverse effect.  
𝜀 = 𝑑 × 𝐸      (1) 
However, the electric field across the element is related not only to the voltage applied to the 
electrode pads and geometric configuration, but also the resistive and capacitive elements in the 
circuit, including those of the piezoelectric aluminum nitride element. The input voltage is 
effectively filtered in a similar way as a low pass RC filter in producing the actuation. As all of 
the input voltage changes used in this study were step functions (increasing and decreasing), the 
differential equation for the effect of an RC filter has a simple time-domain solution, forming the 
basis of Equation (2):  
∆𝛿 = 𝐴∆𝑉𝑝𝑢𝑙𝑠𝑒(1 − 𝑒
−𝑡 𝜏⁄ )     (2) 
where Δδ is the change in position (deflection) of the tip of the cantilever, A is the parameter 
relating the voltage across the AlN element to the cantilever deflection and is related to the 
piezoelectric coefficient and physical layout of the device, ΔVpulse is the change in voltage of the 
input step function, t is the time since the square wave initiation, and τ is the time constant of the 
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circuit. The measured deflection from the optical detection system was fit to Equation (2) using a 
least-squares regression method to determine A and τ.  
 
Figure 27: Actuation of piezoelectric cantilevers. (a) Schematic of optical deflection system. (b) 
Piezoelectric cantilever actuation under a 5V monophasic 150 ms stimulation pulse. (c) 
Piezoelectric cantilever actuation under a ±5V biphasic (total duration 300 ms) stimulation pulse. 
Slight offset observed at end of actuation in (a) and (b) due to baseline drift in raw data (Figure 
28). 
 
Figure 28: Raw data from actuation of piezoelectric cantilevers. (a) Piezoelectric cantilever 
actuation under a 5V monophasic 150 ms stimulation pulse. (b) Piezoelectric cantilever actuation 
under a ±5V biphasic (total duration 300 ms) stimulation pulse.  
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Results and Discussion 
 
Piezoelectric sensing for cardiomyocyte force measurements 
 
To demonstrate that the piezoelectric cantilevers could produce electrical signals from 
cardiomyocyte contraction, human iPSC-derived cardiac muscle was grown on the piezoelectric 
cantilevers in the serum-free medium. Confocal microscopy of the cardiomyocytes on the 
piezoelectric cantilevers (Figure 26A) shows the cardiomyocytes integrated on the top of the 
cantilever surface, with a muscle-specific structural protein myosin heavy chain (red) and nuclei 
(blue) visible. These cardiomyocytes formed a syncytium of contracting cardiomyocytes, and 
this syncytium beat spontaneously due to the presence of pacemaker cells in the culture. Using 
the direct piezoelectric effect, the piezoelectric cantilevers converted the mechanical strain 
caused by the cardiomyocyte contraction into an electrical output. Figure 26B shows a simplified 
schematic of the MEA amplifier system setup used for cardiomyocyte force measurements. The 
real-time, continuous electrical signals generated by the piezoelectric AlN, in response to the 
cardiomyocyte tissue bending of the cantilever, were recorded when the PCB was connected to 
an external amplifier. To demonstrate that the system was capable of measuring changes in 
cardiomyocyte function, 3 µM epinephrine was added to the medium to increase beat frequency 
of the cardiomyocytes.(181) Upon addition of epinephrine, the change in cardiomyocyte beat 
frequency was clearly observed, with an increase in frequency by a factor of more than two. 
Figure 26C indicates clear peak shapes with measurable amplitude and frequency for both the 
spontaneous cardiomyocyte contractions (top) and for the cardiomyocyte contractions induced 
by the addition of epinephrine (bottom).  
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Actuation of piezoelectric cantilevers 
 
The ability of the piezoelectric cantilevers to serve as actuators for applying mechanical stress to 
tissue constructs was evaluated using an optical beam displacement method (Figure 27A) to 
measure the deflection of the piezoelectric cantilever under a periodic waveform of applied 
voltage. Using the inverse piezoelectric effect, when the electric signal was applied to the 
piezoelectric aluminum nitride element, the aluminum nitride converted the electrical pulse into 
a mechanical deformation, causing the cantilever to bend. The actuation of the piezoelectric 
cantilevers was modeled electrically following a simple RC circuit,(182) and captures the 
capacitance of the platinum/aluminum nitride/platinum stack as well as the bulk resistance of the 
aluminum nitride and the resistance of the wires and other series elements in the circuit. Because 
of the effective resistance and capacitance of the circuit, the shape of the input actuation signal 
was not exactly reflected in the actuated cantilever beam. A transfer function model relating the 
output deflection to the input voltage signal was determined to better understand the behavior of 
the piezoelectric cantilevers as actuating elements and to help determine input functions to 
produce desired deflection waveforms.  Figures 27A and 27C show the recorded cantilever 
deflection (black) of the 5V monophasic square wave input and 5V biphasic square wave, 
respectively, and the modeled transfer function (red) for each stimulation input. In both the 
monophasic and biphasic stimulations, the modeled transfer function very closely resembles the 
stimulated actuation signal. There is a slight offset in the actuation signals for both the 
monophasic and biphasic stimulations due the baseline drift in the raw data as shown in Figures 
28A and 28B, respectively. Fitting these two models separately, the monophasic and biphasic 
models had an average τ of 0.014s, and average A of 0.31 µm/V.  
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For use with mechanosensitive cells, such as intrafusal skeletal muscle fibers innervated by 
sensory neurons as part of the stretch reflex arc, simple functions, such as square waves, are not 
sufficient to mimic physiological strain profiles needed to trigger sensory neuron action 
potentials. Instead, an isometric contraction profile would be desired to stretch the intrafusal 
fibers to activate the mechanoreceptors in the sensory neuron’s axons to initiate an action 
potential. The transfer function between time-dependent input voltage and time-dependent 
deflection, developed here, could be used to generate the required input waveform to produce the 
desired output deflection. Equation (3) relates the required applied voltage waveform to the 
desired voltage across the piezoelectric element for an arbitrary waveform: 
𝑉𝑎𝑝𝑝𝑙𝑖𝑒𝑑(𝑡) = 𝜏
𝑑𝑉𝐴𝑙𝑁(𝑡)
𝑑𝑡
+ 𝑉𝐴𝑙𝑁(𝑡)     (3) 
where Vapplied(t) is the input voltage waveform, τ is the time constant (0.014s), and VAlN(t) is the 
voltage across the AlN element. As the deflection of the cantilever tip is related to the voltage 
across the AlN element according to the inverse piezoelectric effect (Equation 4): 
 δ(t) = AVAlN(t),       (4) 
Equation (3) can be modified to relate the output deflection and voltage applied as time series 
(Equation 5): 
𝑉𝑎𝑝𝑝𝑙𝑖𝑒𝑑(𝑡) =
1
𝐴
(𝜏
𝑑𝛿(𝑡)
𝑑𝑡
+ 𝛿(𝑡))     (5) 
where δ(t) is the desired deflection of the tip of the cantilever, and A and τ are as in Equation (2). 
For an arbitrary desired actuation profile (δ(t)) such as to mimic an isometric muscle contraction, 
Equation (5) can be used to determine the input voltage waveform needed. This indicates that the 
piezoelectric system could be used to stimulate intrafusal fibers to generate action potentials in 
sensory neurons. 
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Conclusion 
This work demonstrates the development of a new method using piezoelectric cantilevers to 
measure contractile muscle force generation in human cells by acquiring a real-time, continuous 
and direct electrical signal generated in the piezoelectric AlN, caused by the muscle tissue 
bending the cantilever. This sensor was able to detect spontaneous cardiac muscle contraction 
with enough sensitivity to observe changes in contraction frequency induced by the addition of 
epinephrine. The piezoelectric cantilevers were additionally shown to function as actuators, with 
a defined filtering effect of the input signal to cantilever deflection. The actuation experiments 
enabled the determination of coefficients relating the input voltage waveform to cantilever 
deflection, which can be used to determine the required input voltage waveforms to produce a 
desired arbitrary actuation profile. The ability of these piezoelectric cantilevers to actuate opens 
the opportunity for use with mechanosensitive cells, such as those in the sensory segment of the 
stretch reflex arc to stretch intrafusal fibers. These piezoelectric cantilever devices, which were 
designed to be incorporated into “body-on-a-chip” systems, have the potential to enable 
functional experiments with mechanosensitive tissue structures such as those in the stretch reflex 
arc, to incorporate these tissues into “body-on-a-chip” devices, and to increase the throughput of 
measurements of cardiac and skeletal muscle mechanical function in “body-on-a-chip” devices 
for basic physiological investigations, pharmaceutical compound development, toxin detection, 
neurological and muscular disease modeling for therapeutic development, and predictive 
toxicology.(183, 184) Integration of human skeletal muscle fibers on the piezoelectric cantilevers 
would enable a more robust method to study the human central nervous system and improve 
understanding of spinal cord injuries, diseases such as amyotrophic lateral sclerosis (ALS), 
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CHAPTER SEVEN: GENERAL DISCUSSION 
 
Animal models have proven insufficient for demonstrating human, molecular biology, and 
clinical response to drugs (1, 76). Movement toward more human-based preclinical testing 
platforms is becoming more essential for accurate predictions of human biology and drug testing. 
Also, many governing bodies have chosen to move away from animal models and move closer to 
more ethical human-based in vitro testing platforms for drug safety evaluation and product 
development. As a solution to these issues, “body-on-a-chip” technology has become 
increasingly prevalent in human-based research. This technology integrates MEMS technology 
with human-based cell culture to develop platforms for elucidating functional data based on 
specific organ systems (77). Development of these systems to incorporate multiple facets of 
human health enables the rapid and efficient progression of human disease research and drug 
discovery.  
Multiple in vitro platforms already exist for various investigative pathways. The neuromuscular 
reflex arc, however, is a particularly challenging system to recapitulate in an animal-free 
platform. In the in vivo reflex arc, both descending and ascending neuromuscular pathways 
interact to form complex interactions with the CNS and the environment. While many of these 
intracellular interactions and cell types have been demonstrated in other in vitro platforms, this 
work describes the first functional evidence of γ-motoneuron innervation in vitro, the only 
demonstration of intrafusal fiber differentiation from the increasingly clinically relevant iPSCs, 
and insights as to how to incorporate complex aspects of afferent signaling into “body-on-a-
chip” technology.  
The complexity of the neuromuscular reflex arc yields itself to misunderstandings, particularly 
regarding cellular communication. Outside of this work, motoneuron innervation of extrafusal 
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fibers (13, 37, 82), sensory neuron innervation of intrafusal fibers (14, 15), and interactions 
between motoneurons and sensory neurons (81) has been established. However, γ-motoneuron 
innervation of intrafusal fibers had not been demonstrated. This important cellular interaction is 
vital for the accurate sensation and proprioception of skeletal muscle (87). To establish a 
complete model of the neuromuscular reflex arc, γ- motoneuron contribution must be considered. 
This work demonstrates both molecular and functional evidence of human γ-motoneuron 
innervation in vitro. Co-culture conditions were established for the survival of both human 
motoneurons and intrafusal fibers (Figures 11, 12, and 15). Upon morphological analysis, these 
cultures had developed close cell to cell interactions indicative of innervation (Figure 10 G). As a 
confirmation of communication ability, the cultures were stained to confirm the identities of the 
cell types involved and to establish molecular evidence of innervation (Figures 11 and 13). 
Furthermore, functional evidence was established by stimulating the motoneurons to send signals 
to the intrafusal fibers which they innervated (Figure 15). Collectively, these data show the in 
vitro establishment of γ-motoneuron innervation of intrafusal fibers. This interaction can now 
become integrated into current neuromuscular reflex arc testing platforms for a more detailed 
perspective on neuromuscular responses to drug treatment, disease states, and development.  
Current neuromuscular evaluation platforms can evaluate certain aspects of human biology such 
as exercise (135) and therapeutics (124). However, certain neuromuscular diseases, such as ALS 
and SMA, have genetic components that are difficult to functionally recapitulate in vitro or even 
in animal models. Therefore iPSCs are gaining demand for their use in evaluation of genetic 
diseases. In relation to the neuromuscular reflex arc, extrafusal fibers (130), motoneurons (128), 
and sensory neurons (129) have been differentiated from iPSCs but this work is the first 
demonstration of intrafusal fiber differentiation with morphological (Figure 18) and 
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immunocytochemical (Figures 19 and 20) evidence. Establishment of this cell line permits the 
integration of these cells into neuromuscular reflex arc testing platforms for analysis of afferent 
related disfunction, development, and drug response.  
Several aspects of the afferent spindle signal, including the muscle spindle and nociceptors, can 
be linked to the sensation of pain (141, 143, 144, 147, 148, 153). Therefore, it is vital to consider 
these aspects when developing a preclinical model to evaluate potentially pain-related disease 
states and drug testing. This work evaluates the potential for integrating nociceptors and 
intrafusal fibers into a pain-centered neuromuscular reflex arc testing platform. Sensitization of 
nociceptor endings within the muscle spindle has been of recent interest (17). Potential 
interactions between nociceptors and other cells more frequently found in the muscle spindle 
may possibly explain some of the more elusive aspects of neuropathic pain generation. 
Establishment of neuropathic pain in vitro is a current challenge for pain research. While it is not 
possible to interrogate cells for level of pain perception, neuropathic-related neuronal activity is 
possible to demonstrate. This work shows the electrophysiological response of nociceptor marker 
positive sensory neurons to a common nociceptive agonist, capsaicin, establishing a potential for 
in vitro pain analysis (Figure 22). Additionally, the expression of pain-related receptors on 
intrafusal fibers suggests a possible role in noxious afferent signaling (Figure 23). 
Afferent signaling interrogation presents as a challenging aspect of neuromuscular reflex arc 
research. While sensory neurons can receive and send signaling in a variety of ways (81), 
intrafusal fibers must be mechanically stimulated (185).  To overcome this challenge, aluminum 
nitride, a piezoelectric material, can be integrated into existing cantilever systems for mechanical 
stimulation of intrafusal fibers. This work outlines a method for developing the first 
mechanically interrogative neuromuscular reflex arc testing platform, allowing for the 
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mechanical stimulation of intrafusal fibers and observation of subsequent signal propagation. 
This advancement enhances the investigational capabilities of in vitro functional analysis, 
particularly regarding complex neuromuscular interactions. 
Collectively, these data demonstrate a significant advancement in the field of afferent 
neuromuscular activity research. Integration of γ-motoneurons, iPSC-derived intrafusal fibers, 
human-derived nociceptors, and mechanical interrogation into existing in vitro research allows 
for substantial advancement in animal-free preclinical analyses.  
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